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Summary 
 
Ongoing investigations during the last decade showed that innate immune cells are capable to 
induce memory-like (adaptive) responses such as trained sensitization and tolerance, after 
repeated challenge by the same or different stressors (PAMPs). These effects are imposed by 
epigenetic modifications and followed by metabolic changes of immune cells, resulting in partly 
long-lasting alterations in their inflammatory response, thus affecting different cellular processes 
of innate immunity. 
Recent investigations identified the pathogen dose, in addition to pathogen molecule, as critical 
factor for the mediation of trained sensitization - priming by low-dose PAMPs, and tolerance - 
priming by high-dose PAMPs, suggesting a dose-dependent induction of enduring immune 
patterns in innate immune cells. These findings characterize different metabolic rearrangements 
as critical for the induction of two contrasting patterns of immune response: trained sensitization 
where low amounts of PAMPs provoke resistance mechanisms aiming at pathogen elimination 
leading among others to increased production of pro-inflammatory cytokines, as well as 
tolerance induced by high loads of PAMPs shifting from resistance to maintenance and repair 
mechanisms resulting with a response profile characterized by a dampened pro-inflammatory 
cytokine release. 
Microglial cells as long-living resident immunocompetent cells of the CNS represent 
macrophage-like cells that survey the brain microenvironment in order to secure homeostatic 
conditions for typical neural functions. Any pathological event or injury in CNS triggers the 
activation of microglial cells exhibiting a wide range of phenotypes and functions aiming either 
to induce maintenance and repair mechanisms or to worsen the severity of the injury in the brain. 
Furthermore, these events depend on various molecular signatures induced by different stressors, 
e.g. pathogen conserved structures such as PAMPs as well as damage associated molecular 
patterns (DAMPs) resulting in distinct response patterns of microglial cells such as cytokine 
profiles as well as and other immune cell functions (e.g. phagocytosis). 
Phosphoinositide 3-kinase γ (PI3Kγ) as a major signaling protein is activated by G protein-
coupled receptors (GPCRs), thus triggering the rapid phosphorylation of phosphatidylinositol-
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4,5-bisphosphate (PIP2) into phosphatidylinositol-3,4,5-trisphosphate (PIP3) resulting in 
activation of protein kinase B/Akt downstream signaling mechanisms. In addition, studies have 
shown that PI3Kγ can bind and subsequently induce the activation of other proteins such as 
phosphodiesterases (PDE), modulating cAMP-related signaling. This scaffold function indicates 
a lipid kinase-independent activity in addition to its well-characterized enzymatic properties. 
Previous group data have reported that lipid kinase-dependent and -independent activities of 
PI3Kγ are key mediators of different microglial functions such as migration, proliferation, 
phagocytosis, as well regulating the production of ROS and cytokines, representing PI3Kγ as a 
putative signaling protein important for the induction of trained sensitization and tolerance. 
The aim of this study was to investigate the dose-dependent induction of trained sensitization and 
tolerance by different pathogen conserved structures (LPS, β-glucan) in microglial cells. 
Furthermore we hypothesized that PI3Kγ regulates different metabolic changes, critical for the 
development of adaptive responses, thus affecting microglial functions such as phagocytosis. 
Our data revealed that microglial cells, when primed by low-dose PAMPs (LPS, β-glucan) and 
challenged subsequently with the same or different pathogen, respond with increased production 
of pro-inflammatory cytokines – trained sensitization. In contrast, cells primed by high-dose 
PAMPs induce a robust tolerance phenotype with reduced pro-inflammatory and increased anti-
inflammatory response. The induction of trained sensitization and tolerance was mediated by 
different metabolic changes (glycolysis and oxidative phosphorylation), affecting the microglial 
phagocytosis. Furthermore, our study revealed a tight regulation of the cytokine profile, 
metabolic events and phagocytosis by lipid kinase-dependent and -independent activities of 
PI3Kγ in microglial cells. 
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Zusammenfassung 
 
Neuere Untersuchungen des letzten Jahrzehnts zeigten, dass Immunzellen der angeborenen 
Immunabwehr in der Lage sind, Gedächtnis-ähnliche (adaptive) Reaktionen, d.h. trainierte 
Sensibilisierung bzw. Toleranz, auszuprägen, nachdem sie mit denselben oder verschiedenen 
Stressoren (PAMPs) mehrfach konfrontiert wurden. Diese Wirkungen werden durch 
epigenetische Modifikationen und resultierende metabolische Veränderungen verursacht, die mit 
der Induktion von Entzündungsreaktionen der Zellen einhergehen und dabei verschiedene 
zelluläre Prozesse der angeborenen Immunität beeinflussen. 
Aktuelle Untersuchungen identifizierten die Stressoren-Dosis zusätzlich zum jeweiligen 
Stressoren-Molekül als kritischen Faktor für die Vermittlung von trainierter Sensibilisierung 
(Priming durch niedrig dosierte PAMPs) sowie Toleranz (Priming durch hochdosierte PAMPs), 
was auf eine dosisabhängige Induktion dauerhafter Muster von Immunantworten der 
angeborenen Immunabwehr hindeutet. Diese Befunde charakterisierten dabei verschiedene 
metabolische Umstellungen als kritisch für die Induktion dauerhafter Muster von 
Immunantworten der angeborenen Immunabwehr: Induktion von trainierter Sensibilisierung, 
induziert durch geringe Mengen von PAMPs, die Resistenzmechanismen zur 
Pathogeneliminierung provozieren und dabei zu einer erhöhten Produktion von 
proinflammatorischen Zytokinen führen;  Toleranz, induziert durch hohe PAMPs-Dosen, dass 
durch Aktivierung von Reparaturmechanismen zu Resistenzverhalten führt und dabei unter 
anderem eine Dämpfung des proinflammatorischen Profil von Immunzellen zur Folge hat. 
Mikrogliazellen als langlebige residente immunkompetente Zellen des ZNS überwachen 
fortlaufend die Mikroumgebung im Gehirn, um homöostatische Bedingungen für die neuronalen 
Funktionen zu sichern. Jedes pathologische Ereignis, insbesondere jede Verletzung im ZNS löst 
die Aktivierung von Mikrogliazellen aus, die ein breite Spektrum von Phänotypen und 
Funktionen annehmen können, die entscheidend dazu beitragen, Reparaturmechanismen zu 
induzieren oder daran beteiligt sein können, die Schwere der Verletzung im Gehirn zu 
verschlimmern. Obgleich die Details zur Regulation der jeweiligen zellulären Reaktionsmuster 
noch unzureichend verstanden sind, wurde nachgewiesen, dass  letzteres durch verschiedene 
konservierte molekulare Signaturen entscheidend beeinflusst wird. Dies schließt neben 
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körpereigenen Stressoren (Alarmine), die bei Verletzungen oder Zellschädigungen freigesetzt 
werden (DAMPs), insbesondere pathogenkonservierte Signaturen, wie PAMPs ein und 
modifiziert maßgeblich auch das Zytokinprofil aktivierter Mikrogliazellen einschließlich anderer 
immunrelevanter zellulärer Funktionen (z. B. Phagozytose). 
Phosphoinositid-3-Kinase γ (PI3Kγ) als Signalprotein wird durch G-Protein-gekoppelte 
Rezeptoren (GPCRs) aktiviert, wodurch eine rasche Phosphorylierung von Phosphatidylinositol-
4,5-bisphosphat (PIP2) zu Phosphatidylinositol-3,4,5-trisphosphat (PIP3) resultiert und eine 
forcierte Aktivierung von Protein Kinase B / Akt -abhängigen Signaltransduktionsmechanismen 
verursacht wird. Darüber hinaus haben Studien gezeigt, dass PI3Kγ Proteinkomplexe ausbilden 
kann, das deren Aktivierung zur Folge hat (wie z.B. Phosphodiesterasen), wodurch u.a. cAMP-
abhängige Signalwege modifiziert werden können. Somit weist PI3Kγ neben seinen 
enzymatischen Eigenschaften auch Lipidkinase-unabhängige Funktionen auf. Frühere 
Untersuchungen der Arbeitsgruppe wiesen nach, dass Lipidkinase-abhängige und -unabhängige 
Aktivitäten von PI3Kγ wesentliche Funktionen aktivierter Mikroglia- regulieren (u.a. Migration, 
Proliferation, Phagozytose sowie die Produktion von ROS und Zytokinen). Somit war es 
naheliegend zu vermuten, dass PI3Kγ auch ein relevantes Signalprotein für die Regulation von 
trainierter Sensibilisierung und Toleranz darstellen könnte. 
Das Ziel dieser Studie war es zu untersuchen, ob eine dosisabhängige Induktion von trainierten 
Sensibilisierung und Toleranz durch unterschiedliche pathogene Stressoren (LPS, β-Glucan) bei 
Mikrogliazellen nachzuweisen ist. Darüber hinaus stellten wir die Hypothese auf, dass PI3Kγ 
verschiedene metabolische Veränderungen reguliert, die für die Entwicklung adaptiver 
Antworten von Mikrogliazellen auf repetitive Stressorkontakte von entscheidender Bedeutung 
sind und dadurch Modifikationen adaptiver Immunantworten, wie Phagozytose-Muster 
beeinflussen. 
Unsere Daten wiesen nach, dass Mikrogliazellen, die durch niedrigdosierte PAMPs (LPS, β-
Glucan) geprimt wurden, nach anschließender Exposition mit demselben oder einem anderen 
Erreger, erhöhte Produktion von pro-inflammatorischen Zytokinen zeigten (trainierten 
Sensibilisierung). Demgegenüber bildeten Mikrogliazellen nach Erstkontakt mit hochdosierten 
PAMPs einen robusten Toleranzphänotyp aus, wodurch nach Zweitkontakt mit dem gleichen 
oder einem anderen PAMP ein deutlich reduziertes proinflammatorisches Reaktionsmuster 
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resultierte und eine verstärkte entzündungshemmende Wirkung nachweisbar wurde. Die 
Induktion von trainierter Sensibilisierung und Toleranz wurde durch unterschiedliche 
metabolische Veränderungen (Glykolyse vs. oxidative Phosphorylierung) vermittelt. Darüber 
hinaus konnte nachgewiesen werden, dass bei Mikrogliazellen durch Lipidkinase-abhängige und 
-unabhängige Aktivitäten von PI3Kγ maßgeblich die Regulation des Zytokinprofils, 
metabolische Modifikationen und andere immun-relevante Zellfunktionen (z. B.Phagozytose-
Aktivität)  bewirkt werden. 
1 
 
I. Introduction 
 
1.1. The pathogen dose as crucial determinant for memorizing enduring adaptive 
responses 
“The dose makes the poison” (lat. “Sola dosis facit venenum”) is one of the fundamental dictums 
of Paracelsus, showing the importance of dose as crucial for the definition of its outcome in 
different organisms. Currently it was reported that innate immune cells are capable to mount 
memory-like responses, functionally in principal comparable with the immunological memory of 
the acquired arm after subsequent challenge (Kleinnijenhuis et al. 2012). Both of these adaptive 
responses, sensitization (“training”) as a resistance mechanism aims to the reduction of the 
number of invading pathogens, and tolerance (“desensitization”) which aims toward maintenance 
and repair mechanisms, were reported to be dependent on the nature of the stressors such as 
pathogen-associated molecular patterns (PAMPs) (Quintin et al. 2012). Epigenetic modifications 
imposed by the first hit with resulting changes in gene transcription and resulting metabolic 
changes rearrangements were disclosed as the basis for the development of a these adaptive 
memory-like effects in innate immune cells (Saeed et al. 2014). 
Recent evidences have reported that priming of innate immune cells is shaped not only by the 
pathogen molecule, but also by the pathogen dose. Corresponding studies showed that 
monocytes sensitize priming with low-dose lipopolysaccharide (LPS), after repeated challenge 
inducing increased release of pro-inflammatory mediators such as cytokines (TNF-α, IL-6) and 
reactive oxygen species (ROS) (Chen et al. 2015; Yuan et al. 2016). Furthermore, priming with 
high-dose LPS induced prolonged reduction of inflammatory cytokines. Together these 
experiments identify the concentration of PAMPs as the critical mediator of trained sensitization 
and tolerance responses in monocytes, suggesting a general long-term (enduring) reaction pattern 
of innate immune cells that predominantly depends on the dose of conserved structures of 
different pathogens sensed by the cell (Bauer et al. 2018).  
The above mentioned findings have been explained by different metabolic changes 
characterizing innate immune cells. Low amounts of different PAMPs provoke energy-
demanding resistance responses aiming at pathogen elimination, serving as an adequate state to 
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maintain production of cytokines, antimicrobial peptides, and other defense mediators (Arts et al. 
2016b). In contrast, high doses of pathogens increases impairing mechanisms by affecting the 
capacity of the cells to combat cytotoxic effects of the stressful stimulus triggering the shift from 
resistance responses toward maintenance and repair activities enabling tolerance responses 
against pathogens (Soares et al. 2014; Jha et al. 2015). Adenosine monophosphate-activated 
protein kinase (AMPK) and mechanistic target of rapamycin (mTOR) were reported as nodal 
points of intracellular signaling of both long-term adaptive responses, where mTOR promotes 
sensitization (training) with related metabolic changes, whereas AMPK is involved in 
maintenance effects associated with reduced LPS-induced of TNF-α release in macrophages 
(Cheng et al. 2014; Kim et al. 2014). Furthermore recent attempts were made in order to define 
the molecular mechanism behind innate immune adaptive responses induced by increasing loads 
of pathogen, where low doses of PAMPs or damage-associated molecular patterns (DAMPs) 
trigger the release of ROS and the direct or indirect activation of phosphoinositide 3-kinase 
(PI3K)/mTOR signaling pathway (Bauer et al. 2018). 
Similar biphasic hormetic responses were reported also by other stressors such as heat, cold, 
toxins, radiation or either dietary restriction where low amounts induce anabolic processes 
mediated by mTOR signaling, whereas high doses activate AMPK and lead to maintenance 
operations and related catabolic reactions (Reiling and Sabatini 2006; Jeon 2016). 
Taken together, these data underline the key importance of the sensing dose of stressors (here 
pathogens) for the development of innate immune-mediated adaptive responses. Thus we 
hypothesize a dose-dependent promotion of sensitization and tolerance by innate immune cells, 
such as microglial cells, as a fundamental principle for the pathogen induced adaptive response. 
 
1.2. Trained sensitization and tolerance as new paradigms of the innate immunity  
Years along the immune system in vertebrates has been categorized into two arms of immunity, 
the innate and the acquired immunity. The innate immune cells have been characterized to be the 
first line fighting invading pathogens, fast responding, non-specific and lacking on 
immunological memory. Innate host defenses are mediated by cellular and humoral responses 
involving cells such as monocytes, macrophages, neutrophils, natural killer (NK) cells, and the 
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brain resident cells- microglia as well as the complement system (Rivera et al. 2016). In the other 
hand the acquired immunity consists of specialized cells, T and B cells, which respond slowly, 
are specific and posses the ability to build the immunological memory against specific pathogens 
because of somatic hyper-mutation. The latter consists of accelerated somatic mutations and 
V(D)J recombination (an irreversible genetic recombination of antigen receptor gene segments) 
(Yancopoulos and Alt 1985). 
In the past, perceived absence of immune memory of the innate immunity has been seen as a 
disadvantage considering them as evolutionary primitive. However, observations that children 
vaccinated with the Bacillus Calmette-Guérin (BCG) vaccine resulted in long-term decreased 
morbidity due to infections other then tuberculosis, was recognized to be a non-specific 
protection mechanism against pathogens mainly induced by innate immunity (Garly et al. 2003; 
Netea et al. 2011). Later on, studies done on macrophages and NK cells showed that priming of 
these cells with β-1,3-(D)-glucan (β-glucan) from C. albicans or with any viral ligands such as 
glycoproteins and double-stranded RNAs (dsRNAs) originating from respiratory syncytial virus 
(RSV), upon reinfection undergo a secondary expansion characterized with an increased pro-
inflammatory cytokine profile and the induction of protective responses (Guillot et al. 2005; Sun 
et al. 2009; Ifrim et al. 2014).  
 
Figure 1: Trained sensitization and tolerance as memory-like activities in the innate immunity. 
The illustration shows both of the adaptive responses of the innate immunity. Priming of the innate 
immune cells followed by a second challenge later on leads to elevated levels of pro-inflammatory profile 
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promoted by epigenetic modifications – enhanced trimethylation of histone H3K4 (H3K4me3) inducing 
trained sensitization. In contrast, some PAMPs like LPS, down-regulate the expression of the pro-
inflammatory after subsequent challenge, inducing a tolerant response, characterized by the loss of 
H3K4me3- remaining silent upon restimulation. Adopted from (Stevens et al. 2016). 
 
Taken together, it become clear that the innate arm of the immunity is also able to display 
memory-like properties named trained immunity (sensitization), different from the acquired 
immunity, characterized with enhanced levels of cytokine production (Netea et al. 2011).  
In contrast, the phenomenon of endotoxin tolerance is defined as a shift toward an immuno-
suppressive (anti-inflammatory) response, characterized by reduced inflammatory response of 
the innate immune cells after subsequent challenge with LPS (Cavaillon and Adib-Conquy 
2006). Observations showed that animals are able to survive a lethal dose of bacterial endotoxin 
if they had been previously treated with a sublethal injection (West and Heagy 2002). Therefore, 
considering that uncontrolled systemic inflammatory response, induced by PAMPs such as LPS 
and mediated by a storm of pro-inflammatory cytokines resulting in a life threatening sickness 
syndrome including cardiovascular dysregulation (endotoxin shock), tissue damage, and others, 
thus (endotoxin) tolerance protects the affected organism by controlling (damping) the 
inflammatory state to prevent any hyper-inflammatory responses and serves as an important 
mechanism for host protection (Biswas and Lopez-Collazo 2009). The ability of the innate 
immune cells to induce trained sensitization and tolerance shows that the immune system in 
mammals represents an integrated continuum between innate and acquired immunity. 
 
1.2.1. Trained sensitization in the innate immune cells 
The dichotomy of innate and acquired immunity as components of the immune system represent 
not any sharp division as it was thought previously. The ability of innate immune cells to mount 
a memory-like behavior, functionally similar to the immunological memory of the acquired arm 
after subsequent infection has been termed as trained immunity (innate memory) (Netea and van 
der Meer 2017). These adaptive features can offer protection against reinfections by the same or 
different pathogens mediated independently of the classic acquired immunity (Sun et al. 2009; 
Paust et al. 2010). 
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Initial evidences of trained immunity in mammals have been reported with BCG vaccination and 
by priming the monocytes with β-glucan, as reported above (Ifrim et al. 2014). This contribution 
also pointed out a pathogen-dependent induction of adaptive mechanisms, where pathogen 
conserved components, PAMPs like β-glucan, BCG vaccine or modified lipoproteins such as 
oxidized low-density lipoprotein (oxLDL) or crystal hemozoin (Hz) of the malaria parasite 
(Plasmodium falciparum) - induce (in principle) trained sensitization characterized by enhanced 
levels of the pro-inflammatory response (e.g. TNF-α, IL-6) (Fig. 1) (Ifrim et al. 2014; Schrum et 
al. 2018). 
Several findings have shown that trained immunity is mainly induced by epigenetic changes 
followed by metabolic modifications. A study showed that Dectin-1 activation by β-glucan 
during trained sensitization results with the activation of the protein kinase B (Akt)/mTOR 
pathway resulting with increased expression of HIF-1α, reflected with a metabolic shift toward 
aerobic glycolysis and characterized with enhanced levels of lactate production (Cheng et al. 
2014; Arts et al. 2016b; Novakovic et al. 2016). They further reported that metformin, a mTOR 
inhibitor, was able to abolish the training effect induced by β-glucan through the Akt/mTOR 
pathway, mainly by indirect activation of AMPK, in addition to its capacity to combat C. 
albicans infection. Recently was shown that mediation of trained sensitization in monocytes is 
mainly induced by the metabolic changes, shifting toward glycolysis and glutamine metabolism, 
regulated by Akt/mTOR pathway and dependent on epigenetic reprogramming such as histone 
modifications (Arts et al. 2016a). Epigenetic reprogramming in the case of trained sensitization 
are characterized with methylation or acetylation of histones, leading to sustained changes in the 
transcription programs that do not involve permanent genetic changes such as mutations (Netea 
et al. 2016). 
As mentioned above, trained sensitization has been mainly characterized by increased production 
of pro-inflammatory cytokines (such as TNF-α, IL-6, IL-1β) accompanied with the upregulation 
of specific histone marks that are involved in the transcription of this cytokine profile, such as 
trimethylation of lysine 4 residue on histone 3 (H3K4me3), methylation of lysine 4 residue on 
histone 3 (H3K4me1), and acetylation of lysine 27 residue on histone 3 (H3K27Ac) (Quintin et 
al. 2012; Crișan et al. 2016). β-glucan as main inducer of trained immunity has been further 
reported to reverse the immune tolerance state induced by the activation of Toll-like receptor 4 
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(TLR4) with LPS, restoring the ability of innate immune cells to mediate trained sensitization 
(Novakovic et al. 2016). 
 
1.2.2. Endotoxin tolerance 
Endotoxin tolerance was first described by Paul Besson early in the 20
th
 century, where he was 
able to observe that repeated injections of typhoid vaccine caused an emerge reduction of the 
vaccine-induced fewer (Beeson 1947). Since then, multiple observations have shown that 
repeated injections of gram-negative bacteria result with decreased inflammatory response of 
innate immune cells provoking a process called endotoxin tolerance with a rather complex 
change in the sensitivity of these cells to pathogens (Gantner and Singh 2007; Foster et al. 2007). 
It was confirmed that LPS, as a major component of the gram-negative bacteria wall is the main 
and the strongest known inducer of the endotoxin tolerance. LPS as a PAMP, is recognized by 
TLR4, leading to the activation of downstream molecules that trigger the activation of nuclear 
factor 'kappa-light-chain-enhancer' of activated B-cells (NFκB), resulting with the production of 
inflammatory cytokines (e.g. TNF-α, IL-6, IL-1β) (Ghosh and Karin 2002). LPS-induced 
tolerance is an active process mediated by epigenetic changes such as the loss of H3K4me3 and 
promotion of trimethylation of lysine 9 residue on histone 3 (H3K9me3) resulting in a reduced 
pro-inflammatory response upon re-challenge (Fig. 1) (Wen et al. 2008; Ifrim et al. 2014; Doxaki 
et al. 2015).  
Interestingly, when tolerance is induced by LPS, the respective innate immune cells enhance the 
phagocytic capacity as one of the main functions to fight against pathogens (De Lima et al. 
2014). Furthermore, repeated challenge of human mononuclear cells with LPS induce endotoxin 
tolerance, leading to the known immunosuppressive responses characterized by decreased levels 
of pro-inflammatory mediators (TNF-α, IL-6) and increased anti-inflammatory cytokines such as 
IL-10, resulting in a switch toward the M2 state of polarization (Pena et al. 2011). Endotoxin 
tolerance is further characterized by metabolic alterations toward oxidative phosphorylation, 
mainly mediated by increased adenosine triphosphate (ATP) production that promote repairing 
mechanisms (Fensterheim et al. 2017). 
7 
 
The molecular mechanism behind endotoxin tolerance is yet not fully elucidated and 
incompletely understood. Obviously, during endotoxin tolerance a reduction of the pro-
inflammatory cytokine profile occurs, which promotes the IL-10 or TGF-β production, 
respectively as anti-inflammatory mediators. Furthermore, LPS-induced tolerance is 
characterized by downregulation of TLR4/MyD88 pathway and partially promotion of 
TLR4/TRIF pathway leading to downregulation of pro-inflammatory mediators, such as TNF-α, 
IL-6 and iNOS, and resulting in increased levels of IL-10 and TGF-β (Nomura et al. 2000). 
Therefore endotoxin tolerance serves as an important control mechanism to attenuate 
inflammation-associated damages, leading to cellular re-arrangements affecting different 
functional processes in the organism (Chu et al. 2016).  
 
1.2.3. Functional importance of trained sensitization and tolerance 
The ability of the innate immune cells to respond with trained sensitization and tolerance is 
considered to be a new powerful tool for the development of new potential strategies against 
different diseases, especially those who imply inflammatory processes such as microbial 
infections, cardiovascular disease (such as atherosclerosis), neurodegenerative disorders and 
even malignant tumors (Dubois 2015; Norata 2018). Furthermore, understanding the molecular 
mechanism behind trained sensitization and tolerance may help for the development of new 
specific inhibitors, modifiers of the epigenetic reprofiling or metabolic pharmacological 
supplements that could be used for potent treatments of different disorders (van der Meer et al. 
2015). Indeed, hyperactivation of the innate immune cells can lead to maladaptive responses 
promoting a pro-inflammatory setting resulting with progression of the chronic inflammatory 
diseases such as atherosclerosis (Becker et al. 2010; Bekkering et al. 2013).  
Increased attention has been attracted toward current findings that alterations of neuro-
inflammatory responsiveness associated with microglial trained sensitization and tolerance are 
crucially involved in the progression and regression of neurodegenerative disorders. Recent 
investigations showed that induction of trained sensitization in microglial cells trigger the 
exacerbation of the neuropathological diseases (i.e. Alzheimer disease) (Wendeln et al. 2018). 
Similarly, long-term hyperactivation and extensive release of pro-inflammatory mediators seems 
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to affect emotional, behavioral and cognitive properties by inducting neuro-inflammatory 
responses (Talge et al. 2007; Salam et al. 2018). 
Trained sensitization represents therefore a double-edged sword in several functions of the innate 
immunity, because it can contribute to a beneficial host pathogen response, but can also 
aggravate the severity of chronic diseases. 
 
1.3. Microglial cells – role and function in health and diseases 
Microglial cells are long-lived, immunocompetent and resident cells of the central nervous 
system (CNS) that are involved in the maintenance, pathogenesis and repair mechanisms in the 
brain (Streit 2002; Harry and Kraft 2012). Microglial cells originate from early development of 
myeloid progenitors in the embryonic yolk sac and account for around 10% of the cells in the 
central nervous system (Lawson et al. 1990). They represent the brain macrophages, responsible 
for surveying the microenvironment in order to warrant homeostatic conditions for normal neural 
functions (Aguzzi et al. 2013). In any case of tissue disturbance, immediate microglial response 
contributes effectively in elimination of invading pathogens, damaged cells or protein 
aggregates, as well as dysfunctional synapses and antigens in the CNS (Amor et al. 2010). 
Therefore, any pathological event or injury in the CNS lead to the activation of the microglial 
cells that start to proliferate, migrate to the place of injury, become active phagocytes and 
remove debris or dead cells as well as dysfunctional synapses, a process termed “synaptic 
stripping”, affecting or reconstructing structural circuits in the neural network (Saijo and Glass 
2011; Kettenmann et al. 2013).  
Beside their crucial role in homeostatic maintenance, microglial cells are implicated in relevant 
functional alterations of brain development and aging (Luo et al. 2010). Furthermore, they have a 
pivotal role in the generation and progression of the neurodegenerative diseases (Zhang et al. 
2017). Microglial cells produce a wide range of factors important for the maintenance of brain 
homeostasis and defense including chemokines, cytokines and neutrophic factors that trigger 
either an inflammatory cascades or acquire neuroprotective mechanisms that contribute to 
various aspects of immune responses and tissue repair in CNS (Pocock and Kettenmann 2007; 
Colonna and Butovsky 2017). The phenotype of these cells has been characterized based on the 
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morphological features. Seminal in vivo studies pointed out that there is no period of inactivity 
for microglial cells since they constantly scan the brain microenvironment in order to detect 
minor perturbations (Nimmerjahn et al. 2005; Kettenmann et al. 2011; Davis et al. 2017). 
Moreover under surveying state microglial cells have a highly ramified (branched) morphology 
and are able to survey the intact brain by extending and retracting their ramified motile processes 
while constantly contacting synapses (Nimmerjahn et al. 2005). Different stressors act on surface 
receptors of the microglial cells and rapidly activate them leading to morphological (amoeboid 
microglia) and functional changes like secretion of different mediators (i.e. chemokines, 
cytokines) that play a pivotal role in initiation and development of neuro-immunological 
processes (Hanisch 2002). 
Microglia as the main innate immune cells has been also considered as double-edged sword, 
considering the fact that in one hand it can help eliminating pathogens and debris that could be 
harmful, but in the other hand “hyper”-activated microglia can cause severe neurodegenerative 
diseases (Kim and Joh 2006; Santiago et al. 2017). Therefore, an inhibition of “hyper”-activated 
microglia has been considered as a possible key strategy for the prevention and treatment of 
different neurodegenerative diseases like Alzheimer’s diseases, Morbus Parkinson or multiple 
sclerosis, even if there is no approved treatment option so far (Dheen et al. 2007). Moreover, 
chronic activated microglia induces a pronounced phagocytic effect and remains as one of the 
main sources for multiple neurotoxic factors, including here tumor necrosis factor-α (TNF-α), 
interleukin-6 (IL-6), nitric oxide (NO) derived from inducible NO synthase (iNOS), interleukin-
1-beta (IL-1β), and reactive oxygen species (ROS), that drive the progression of the neural 
damage (Lull and Block 2010). One of the observations shows that extensive production of ROS 
and increasing microglial phagocytosis (part of microgliosis) have been crucially involved in the 
mechanism of neurotoxic microglial activation, especially in the Parkinson disease (Roy et al. 
2008).  
Most of the immune receptors in the surveying microglia are quite low expressed, but upon 
activation of the microglia, these receptors are significantly upregulated and stimulate the 
production of inflammatory mediators (Walter and Neumann 2009). One of the most important 
receptor entities that leads to the activation of microglial cells are the family of pattern-
recognition receptors (PRRs) that recognize different conserved pathogen structures (motifs) 
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from microorganisms termed PAMPs or endogenous molecules that originate from stressed cells 
upon tissue damage known as DAMPs (Häcker et al. 2006). 
Different PAMPs activate PRRs and thus affect the PI3Ks/mTOR pathway leading to attenuated 
levels of pro- and anti-inflammatory cytokines in the microglial cells (Weichhart et al. 2015). 
Furthermore, previous studies showed that PI3Kγ, the only member of class IB of PI3Ks, is 
constitutively expressed in microglial cells mediating different microglial functions such as 
migration, phagocytosis, ROS formation and MMP release (Jin et al. 2010; Schmidt et al. 2013; 
Frister et al. 2014; Schneble et al. 2017). 
 
1.3.1. Pattern-recognition receptors (PRRs) as key activators of microglia 
Microglial cells as a part of the innate immune system represent the first line of host defense 
against pathogens. They have been considered to be unspecific and transmit the information as 
antigen-presenting cells to the acquired immune system. Up to date, it was shown that the innate 
immune cells are not completely nonspecific, as was originally thought, but rather are able to 
discriminate between self and a variety of pathogens (Akira et al. 2006). They recognize 
different pathogens by sensing them via distinct PRRs leading to the activation and the 
production of pro-inflammatory cytokines. 
PRRs represent a germline-encoded receptor family that posses the ability to recognize microbial 
components, known as PAMPs, that are essential for the survival of the microorganism and are 
therefore difficult for the microorganism to alter (Nhu et al. 2012). In addition, PRRs also 
recognize different host biomolecules called DAMPs (Wegiel et al. 2015; Hooper et al. 2018). 
Up to date there are four major families of PRRs present in the innate immune cells: Toll-like 
receptors (TLRs) with about 13 murine, respectively 10 human identified members; RIG-like 
receptors (RLRs); NOD-like receptors (NLRs); and C-type lectin receptors (CLRs) with several 
members including here Dectin-1 which is able to recognize fungal components like β-glucan 
(Medzhitov 2007). 
TLRs recognize a variety of different PAMPs with diverse origins (viruses, bacteria, fungus, and 
parasites). They are characterized by an extracellular N-terminal leucine-rich repeats (LRRs) 
domain and a transmembrane region followed by a cytoplasmic Toll/IL-1R homology (TIR) 
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domain (Akira and Takeda 2004; Takeuchi and Akira 2010). Members of TLRs family can 
further be divided based on their recognition preferences for different PAMPs, like them that 
recognize lipids from bacteria (TLR1, TLR2, TLR6) or nucleic structures from viruses (TLR7, 
TLR8, TLR9) (Janeway and Medzhitov 2002). Activation of Toll-like receptors causes 
activation of cascade proteins that induce the translocation of NFκB into the nucleus resulting 
with expression of pro-inflammatory genes and production of different cytokines (of major 
interest TNF-α and IL-6).  
One of the most important receptors of TLRs is TLR4 which recognizes a range of ligands like 
LPS, fibronectin, and heat-shock proteins of different structures (Akira et al. 2006). LPS acts 
through TLR4 with the help of the anchor protein, myeloid differentiation factor 2 (MD-2), and 
activates two divergent pathways: Myeloid Differentiation Factor 88 (MyD88)-dependent and 
MyD88-independent pathway. 
MyD88-dependent pathway is mainly characterized to transmit the activation response through 
the adaptor protein MyD88 triggering the early activation of the transcription factor NFκB and 
thus leading to the production of inflammatory mediators (Kawai et al. 2001). Different, MyD88-
independent pathway leads to the activation of late phase NFκB and interferon regulatory factor 
3 (IRF-3) as transcription factors triggering the production of interferon-beta (IFN-β) and pro-
inflammatory cytokines through transmission of the signal via TRIF (Toll/IL-1 receptor (TIR) 
domain-containing adaptor) as an adaptor protein (Yamamoto et al. 2003). Moreover NFκB is 
not only the prototypical pro-inflammatory signaling pathway but also a key regulator of the 
anti-inflammatory response that regulates the expression of pro- and anti-inflammatory 
mediators, chemokines, and adhesion molecules (Lawrence 2009). 
Dectin-1 receptor as a member of CLRs, is mainly activated from β-glucan and recruits 
downstream regulation of caspase recruitment domain-containing protein 9/ B-cell lymphoma-
leukemia 10/ Mucosa-associated lymphoid tissue lymphoma translocation protein 1 
(CARD9/BCL10/MALT1) complex triggering the activation of NFκB, expressing increased 
production of TNF-α and IL-6 (Plato et al. 2015). Therefore, pathogen-induced upregulation of 
PRRs and related signaling molecules by microglia in the CNS indicates a prominent role in 
neurodegeneration and repairing mechanisms (Kigerl et al. 2014). 
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1.3.2. Different functional activation states of microglial cells 
Microglial cells under healthy conditions have a wide range of important functions such as 
synaptic pruning during development shaping neural circuits in the developing brain, promoting 
the secretion of neutrophic factors such as such as nerve growth factor (NGF) and brain-derived 
neurotrophic factor (BDNF) thus contributing to the formation of learning-dependent synapses or 
by secretion of cytokines supporting the process of neurogenesis (Shemer et al. 2015; Butovsky 
and Weiner 2018). Pathological events trigger the activation of microglia, a predominant process 
that induces neuroinflammation in the central nervous system (Glass et al. 2010). Under the 
influence of different stimuli in vitro, microglia tends to show a polarized phenotype into a pro-
inflammatory (M1) classical activated form or anti-inflammatory (M2) (regenerative) alternative 
activation. Despite all the characteristics between M1 and M2 phenotypes, increasing evidence 
has shown that this kind of arrangement has been helpful for conceptualizing microglia 
responses in vitro, but doesn’t represent the in vivo activation where microglial cells rarely 
display any bias toward any of these states (Ransohoff 2016; Colonna and Butovsky 2017). 
Results from single-cell RNA-sequencing analysis of the infiltrating brain macrophages during 
traumatic brain injury (TBI) failed to support the M1/M2 polarization scheme, suggesting a lack 
of exclusivity in macrophage polarization states in vivo (Kim et al. 2016). In addition an another 
study showed also that during brain injury, macrophages/microglia in a concurrent manner 
express a mixed phenotype, different from the common know polarization phenotypes (Morganti 
et al. 2016). 
Under in vitro conditions, M1 activation represents a pro-inflammatory and neurotoxic state 
induced by LPS or other ligands that trigger the downstream stimulation of TLR pathway, 
inducing the production of a range of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-
1β (Kobayashi et al. 2013). The outcome of M1 microglia includes also high production levels of 
reactive oxygen species (ROS), as well as the inducible nitric oxidase (iNOS) which mainly 
competes with arginase-1 (Arg-1) as M2 mediator, for the metabolism of L-arginine (Orihuela et 
al. 2016). Furthermore, iNOS converts L-arginine into nitric oxide (NO) and citruline having a 
significant impact in the inflammatory state of microglia. In addition, classic activation of 
microglia is characterized with a metabolic switch toward a glycolytic state, driving a sustained 
expression of hypoxia-inducible factor 1-alpha (HIF-1α) (Habib et al. 2014; Van den Bossche et 
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al. 2016). M1 state plays a crucial role responding to injury and it represents the first line against 
invading pathogens in the CNS. 
In contrast, the alternative (M2) activation of microglia promotes the anti-inflammatory state and 
repairing mechanisms induced mainly by IL-4 stimulation. Upon activation, M2 phenotype leads 
to the release of the anti-inflammatory cytokines like IL-10 and TGF-β, neurotrophic factors like 
BDNF, as well increased expression of Arg-1 that constitutively competes with iNOS for L-
arginine metabolism, making it a key factor for the differentiation between M1/M2 phenotype 
activation (Pesce et al. 2009; Avdic et al. 2013; Tang and Le 2016; Taylor et al. 2017). Arg-1 
converts L-arginine into urea and L-ornithine which promotes cell proliferation and tissue repair 
(Landau et al. 2010). Distinct from M1, the M2 microglia are characterized with a pronounced 
oxidative phosphorylation as metabolic change. Furthermore, the M2 phenotype promotes 
parasite clearance, immunosuppression, wound healing and tumor growth (Murray and Wynn 
2011). The M1/M2 polarization concept has been oversimplified in order to explain different 
characteristics of microglial cells, but failed to yield a clear-cut meaningful explanation of the 
transcriptional profile and don’t represents any specific relation to any cellular functions in 
microglia (Grabert et al. 2016). 
 
1.4. PI3Ks family - key signaling proteins of different immuno-responses 
Phosphoinositide 3-kinases (PI3Ks) represent a family of lipid kinases that transduce signals 
from transmembrane receptors such as receptor tyrosine kinases (RTKs) and G protein-coupled 
receptors (GPCRs) to the cytoplasm and results in production of phosphorylated lipids (Akinleye 
et al. 2013). They phosphorylate phosphatidylinositol (PtdIns) and its phosphorylated derivatives 
at the 3′-OH group position of the inositol ring, generating second messengers that control and 
modulate intracellular activities of protein effectors affecting many cellular functions (Bader et 
al. 2005; Martini et al. 2014). PI3Ks control a wide range of cell functions including survival, 
migration, proliferation, metabolism, cell growth and immune responses. Taking under 
consideration that this family of lipid kinases can monitor such a big spectrum of biological 
processes, it is of key importance to study them specifically. Based on the structural similarities 
and substrate specificities, PI3Ks are divided in three classes: class I, further divided in class IA 
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(enzymes: p110α, p110β, and p110δ) and class IB with the only member p110γ; class II with 3 
identified catalytic members (C2α, C2β, and C2γ), and class III with the only one known 
member vacuolar protein sorting 34 (Vps34) (Liu et al. 2009). 
Class IA is the most studied class of PI3Ks, consisting of a regulatory subunit (p85α, p85β or 
p55γ) and a catalytic subunit (p110α, p110β or p110δ) where each member can associate with all 
of the regulatory subunits (Okkenhaug and Vanhaesebroeck 2003). Upon stimulation the 
regulatory subunit binds to the intracellular phosphorylated tyrosine motifs of the activated 
receptor and triggers the activation of the catalytic subunit mediating the phosphorylation of 
phosphatidylinositol-4,5-bisphosphate (PIP2) into phosphatidylinositol-3,4,5-trisphosphate (PIP3) 
which serves as second messenger recruiting the activity of class I PI3Ks (Bader et al. 2005; 
Martini et al. 2014). PIP3 as a secondary messenger acts as a binding site for numerous 
intracellular enzymes that contain PH (pleckstrin homology) domains, especially for serine-
threonine kinase Akt known also as protein kinase B (PKB), as well 3-phosphoinositide-
dependent kinase 1 (PDK1) (Okkenhaug and Vanhaesebroeck 2003; Bader et al. 2005; Yu and 
Cui 2016). Akt is one of the main downstream effectors of PI3Ks that activates effectively the 
mechanistic target of rapamycin complex 1 (mTORC1), glycogen synthase kinase 3 (GSK3), 
tuberous sclerosis complex (TSC), and the forkhead family of transcription factors (FOXOs) 
resulting in increased protein synthesis, metabolism and proliferation (Zhang et al. 2006). PIP3 
serves also as a substrate for phosphatase and tensin homolog (PTEN), which dephosphorylates 
PIP3 into PIP2 and thus results as a negative regulator of PI3K/Akt signaling and functions 
(Malek et al. 2017). Due to pivotal functions of class IB of PI3Ks in the immunologic responses 
in the innate immune responses, especially in microglial cells it will be described in special parts 
below, elaborating crucial cellular functions of the only member, phosphoinositide 3-kinase γ 
(PI3Kγ).  
Class II are monomers that lack on the regulatory subunit binding domains, but possess three 
catalytic isoforms: C2α, C2β, and C2γ (Falasca and Maffucci 2012). They are activated through 
both RTKs and GPCRs, and considered for years long as very enigmatic involved in cell growth, 
vesicular trafficking, and migration (Gaidarov et al. 2001; Falasca and Maffucci 2012; 
Mavrommati et al. 2016). Vps34 is the only identified member of class III of PI3Ks, known to be 
involved in vesicular trafficking and nutrient sensing in the mTOR pathway in mammalian cells 
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(Devereaux et al. 2013). Considering all the above mentioned functions triggered by PI3Ks, 
especially involved in the cancer, there are increasing attempts for discovering new anti-cancer 
therapies by different inhibitors that suppress specifically class I PI3Ks (Zhao et al. 2017). 
 
1.4.1. Class IB of PI3Ks 
Class IB of PI3Ks are heterodimers of a p110γ catalytic subunit coupled with the regulatory 
isoforms p101 or p87 (also known as p84 or p87
PIKAP
) (Thorpe et al. 2015). PI3Kγ as the only 
member of this class is activated by GPCRs, by the interaction of regulatory subunit with Gβγ, 
triggering the rapid phosphorylation of PIP2 into PIP3 as second messenger and thus activating 
Akt/mTOR downstream processes. Several chemokines (e.g. IL-8), bacterial products (e.g. N-
formyl-Met-Leu-Phe (fMLP), LPS) and complement system factors (e.g. C5a) have been shown 
to be able to activate this isoform of PI3Ks and thus regulating cellular functions of the immune 
cells from both innate and acquired immunity (Hawkins and Stephens 2007). PI3Kγ is involved 
in stress-induced inflammatory responses and highly expressed in neutrophils, macrophages, 
mast cells, as well as important due to many reported functions in microglia, T cells, endothelial 
cells (Hawkins et al. 2006; Jin et al. 2010), but also parenchymal cells like cardiomyocytes and 
neurons of the central as well as peripheral nervous system (Patrucco et al. 2004; König et al. 
2010; Perino et al. 2014). 
Chemoattractants interact with GPCRs and activate PI3Kγ resulting with increased production of 
ROS in order to kill the pathogen and leading to inflammatory response (Fruman et al. 2017). 
TLRs recognize different pathogen conserved structures, thus tightly affecting PI3Ks/mTOR 
pathway and attenuating the production of pro- (TNF-α, IL-6, IL-1β) and anti-inflammatory (IL-
10) cytokines (Weichhart et al. 2015). Moreover PI3Kγ represents a crucial mediator of 
inflammatory responses, especially in cardiomyocytes and microglial cells (Ndongson-Dongmo 
et al. 2015; Schmidt et al. 2016). 
PI3Kγ triggers the phosphorylation of PIP2 into PIP3 as a second messenger activating different 
downstream effectors, most importantly Akt and PDK1. Furthermore, PI3Kγ has also been 
shown to be directly activated by Ras, controlling MAPK signaling pathway, such as Jun-N-
terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) cascades (Rückle et al. 
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2006). Moreover, mice lacking PI3Kγ had significantly decreased release of pro-inflammatory 
cytokines and increased protection from septic induced disorders (Vadas et al. 2013). A recent 
work showed that PI3Kγ is a key switch molecule that controls immunosuppression affecting 
NFκB activation, and synergizes with inhibitor therapy to promote long-term tumor regression 
and increased survival (Kaneda et al. 2016).  
PI3Kγ has been reported to control immuno-metabolic responses in the innate immune cells by 
regulating diet-induced obesity, adipose tissue inflammation, and insulin resistance (Breasson et 
al. 2017, 2018). 
 
Figure 2: Dual functions of PI3Kγ, lipid kinase-dependent and -independent. 
Gβγ subunits of G-protein coupled receptors (GPCRs) activates PI3Kγ triggering the phosphorylation of 
PIP2 (phosphatidylinositol-4,5-bisphosphate) into PIP3 (phosphatidylinositol-3,4,5-trisphosphate) and 
activating downstream processes which represents the catalytic activity (lipid kinase-dependent). In the 
other hand PI3Kγ binds to proteins like the regulatory subunit (p101 and p84), PDE (phosphodiesterase), 
Ras and mitogen-activated protein kinase (MAPK) kinase (MEK) mediating a scaffold-function (lipid 
kinase-independent). PTEN (phosphatase and tensin homologue) dephosphorylates PIP3 to PIP2. Adopted 
from (Rückle et al. 2006). 
 
Interestingly, PI3Kγ consists of a dual role (so called “double identity”), not just acting like 
classical kinases by generating PIP3 and inducing downstream signaling processes, but also 
binding with other proteins, especially PDE, indicating a protein-scaffold function in addition to 
its enzymatic activity as shown (Fig. 2) (Rückle et al. 2006; Costa and Hirsch 2010). The 
attempting step to differ and show both of those dual functions of PI3Kγ have been made by 
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using the knock-out (PI3Kγ-/-) and the mutated form knock-in (kinase-dead; PI3KγKD/KD) where 
the kinase activity has been abolished allowing only the lipid kinase-independent function to act 
(Patrucco et al. 2004). They showed that PI3KγKD/KD mice did not alter the cardiac contractility, 
but displayed in addition reduced inflammatory responses. A study from our group has showed 
that the scaffold-function (lipid kinase-independent) induced myocardial depression by 
sequential activation of cAMP and iNOS pathways (Ndongson-Dongmo et al. 2015). 
Altogether, these studies underlined the tight interplay between lipid kinase-dependent and -
independent functions of PI3Kγ, providing a potentially wider set of associations and functional 
relevance. 
 
1.4.2. PI3Kγ role and function in microglia 
There is growing evidence that PI3Kγ plays a pivotal role in controlling a variety of immune 
functions in microglial cells. Frister et al. showed that PI3Kγ lipid kinase-independent function 
mediated LPS-induced extensive matrix metalloproteinase 9 (MMP-9) production in microglial 
cells contributing to the breakdown of the blood-brain barrier (BBB) and thus inducing a neuro-
inflammatory response and subsequently being a key event for the development of sepsis-
induced brain damage (Frister et al. 2014). The data suggested that the PI3Kγ lipid kinase-
independent stimulation of PDE (mainly PDE3B) activity resulting in an inhibition of cAMP 
signaling is a key mediator of LPS-induced MMP release in microglial cells. Another study of 
our group indicated the important scaffold function of PI3Kγ mediating microglial phagocytic 
activity after focal brain ischemia controlled by a PI3Kγ-dependent cAMP signaling (Schmidt et 
al. 2013, 2016). The suppressive effect of PI3Kγ on cAMP levels through the activation of 
PDEs, especially PDE3B, appears to be critical for the restriction of ischemia- induced immune 
cell functions and in turn tissue damage (Schmidt et al. 2016). Furthermore, the lipid kinase-
dependent activity of PI3Kγ that leads to the activation of Akt signaling events is an essential 
mediator of microglial migration and motility provoked by the complement component C5a and 
other chemoattractants (Schneble et al. 2017). Feed-back action of protein kinase A (PKA) 
induced by norepinephrine leads to the inhibition of PI3Kγ activity suppressing the cellular 
activity of migration (Schneble et al. 2017).  
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Therefore, lipid kinase-dependent and -independent activities of PI3Kγ have been shown to have 
either a coordinated or self actions in different downstream effectors affecting different cellular 
functions in microglial cells. Current findings regarding targeted metabolic control, mediated by 
activities of PI3Ks/mTOR pathway, suggest a possibly importance of PI3Kγ in mediating trained 
sensitization and tolerance in microglial cells. 
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II. Hypothesis and aims 
 
2.1. Hypothesis 
The ability of the innate immune cells to respond with trained sensitization and tolerance shows 
that the immune system in mammals represents an integrated continuum between innate and 
acquired immunity (Ifrim et al. 2014). Trained sensitization aims within the target to reduce the 
number of pathogens as protective mechanism, whereas tolerance in the other side affords 
protection against deleterious effects of infectious diseases as a maintaining mechanism (Bauer 
et al. 2018).  
A previous report claimed that microglial cells are capable to induce tolerance response after 
repeated LPS stimulation (Schaafsma et al. 2015). Recently, a study observed dose-dependent 
correlation for the induction of both of adaptive immuno-responses after repeated challenge in 
microglial cells in vivo, displaying the key importance of pathogen dose, especially PAMPs such 
as LPS (Wendeln et al. 2018). Our research group observed dose-dependent effects after single 
stimulation affecting different cellular processes in microglial cells such as phagocytosis, 
migration, proliferation and cytokine release, mediated mainly by lipid kinase-dependent or -
independent functions of PI3Kγ (Schmidt et al. 2013; Frister et al. 2014; Schneble et al. 2017). 
However, the role of different stressors such as LPS and β-glucan to induce adaptive responses 
(trained sensitization and tolerance) in microglia upon re-challenge has not been fully elucidated, 
especially the role of PI3Kγ controlling them. 
Considering the above mentioned findings we hypothesized that different PAMPs such as LPS 
and β-glucan, are able to induce trained sensitization and tolerance responses in a dose-
dependent manner in microglial cells. We further proposed that both, trained sensitization and 
tolerance, in microglia are mediated by the lipid kinase-dependent and/or -independent activities 
of PI3Kγ.  
In addition we postulated that PI3Kγ regulates different metabolic parameters affecting major 
energy changes that are key developments during adaptive responses and influences cellular 
functions in the microglial cells (e.g. phagocytosis). 
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2.2. Aims 
Taking into consideration the above mentioned reports and data we hypothesized a tight 
regulation of trained sensitization and tolerance in microglial cells by PI3Kγ. Our current aims 
for the project were: 
- Deciphering the dose-dependent induction of both of adaptive responses on microglial 
cells, especially low-dose induction of resistance (trained sensitization) and high-dose 
induction of persistence (tolerance). 
- Characterization of M1-like and M2-like microglia phenotypes as putative mechanisms 
helpful for conceptualizing immune responses in vitro, in order to explain trained 
sensitization and tolerance as new paradigms of the innate immunity in the CNS. 
- To investigate the role of metabolic changes affecting different energy parameters in 
microglial cells important for the induction of trained sensitization and tolerance 
responses, mainly regulated by the activity of PI3Kγ. 
- To characterize the molecular mechanism behind trained sensitization and tolerance 
responses in microglial cells mediated by lipid kinase and scaffold activities of PI3Kγ. 
- To elucidate the role of PI3Kγ in different microglial functions, exclusively the 
phagocytic activity, during both of adaptive responses.  
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III. Materials and methods 
 
3.1. Materials 
Table 1: Machines and equipments 
Machine/ Equipment Manufacturer 
Bio-Rad 1000/500 Constant Voltage Power Supply Bio-Rad, USA 
Centrifuge 5415C Eppendorf Eppendorf AG, Germany 
Centrifuge 5416 Eppendorf Eppendorf AG, Germany 
Centrifuge 5417R Eppendorf Eppendorf AG, Germany 
CKX41 Inverted Microscope Olympus Microscopy, Japan 
Cold Light Schott KL 750 Schott AG, Germany 
CX41 Biological Microscope Olympus Microscopy, Japan 
HERAcell vios 160i (cell culture incubator) Thermo Scientific, Germany 
Lab pH Meter inoLab® pH 7110 
Xylem Analytics Germany Sales GmbH 
& Co. KG, WTW, Germany 
LAS4000 camera Fuji Photo Film Co., Japan 
Nanodrop ND-1000 machine Peqlab Biotechnologies, Germany 
Neubauer Counting Chamber Carl Zeiss AG, Germany 
Nikon Eclipse Ti fluorescence Microscope Nikon Instruments, Japan 
Pipette Pipetman Gilson (P10, P20, P100, P200, P1000) Gilson S.A.S., France 
Realplex Mastercycler ep gradient S Eppendorf AG, Germany 
Safe 2020 Class II Biological Safety Cabinet 
(cell culture safety bench) 
Thermo Scientific, Germany 
Sartorius Analytical Balance Sartorius AG, Germany 
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Sartorius Basic Balance BA210 Sartorius AG, Germany 
Seahorse XFe96 Analyzer Agilent Technologies, Germany 
Semi-Dry-Blotting Machine Millipore Graphite, Millipore USA 
Shaker type VF2 IKA-Labortechnik, Germany 
Synergy® UV Water Purification System Merck Millipore, USA 
Systec Autoclave D65 Systec GmbH, Germany 
TECAN Infinite 200 Plate reader Tecan, Switzerland 
Thermo cycler T-Gradient ThermoBlock Biometra, Germany 
Thermo mixer 5436 Eppendorf Eppendorf AG, Germany 
Trans-Blot® SD Semi-Dry Transfer Cell Bio-Rad, USA 
Transferpette® -8 electronic, Multichannel pipette Brand GmbH & Co. KG, Germany 
Tuttnauer Systec 5050 EL Tuttnauer Europe B.V., Netherlands 
Tweezers Carl Roth GmbH & Co. KG, Germany 
VersaMax Microplate Reader Molecular Devices, USA 
Zeiss Stemi 2000 Microscope Carl Zeiss Microscopy, Germany 
Zeiss Telaval 31 Microscope Carl Zeiss Microscopy, Germany 
 
Table 2: General laboratory chemicals, kits, consumables and reagents  
Product Vendor Catalogue Number 
12 Well Cell Culture Plates 
(sterile, with lid) 
Greiner Bio-one 665180 
2,5% Trypsin (10x) Gibco 15090-046 
2’,7’-Dichlordihydrofluorescein-diacetat 
(H2DCFDA) 
Thermo Fisher Scientific D399 
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24 Well Cell Culture Plates 
(sterile, with lid) 
Greiner Bio-one 662160 
2-Mercaptoethanol Fluka Biochemika 63690 
6 Well Cell Culture Plates 
(sterile, with lid) 
Greiner Bio-one 657160 
96 Well Cell Culture Plates 
(sterile, F-bottom, with lid) 
Greiner Bio-one 655180 
ABTS Sigma - Aldrich A1888 
Acetic acid Carl Roth GmbH & Co. KG 3738.5 
Amersham Hybond P 0.45 PVDF blotting 
membrane 
GE Healthcare Bio-Sciences 10600023 
Ammonium persulphate (APS) 
SERVA Electrophoresis 
GmbH 
13375.05 
Amphotericin B solution Sigma - Aldrich 1397-89-3 
Biosphere Filter tips (100 µl) Sarstedt AG & Co. 70.760.212 
Bovine serum albumin (BSA) Sigma - Aldrich A7906 
Bromophenol blue Carl Roth GmbH & Co. KG A512.1 
Calcium chloride (CaCl2) AppliChem GmbH A4689,0250 
cAMP GloAssayKit Promega V1501 
Cell Scraper Greiner Bio-one 541070 
ClearLine® Filter tips (200 µl) 
Dominique DUTSCHER 
S.A.S. - Siège 
014220CL 
Dimethyl sulfoxide (DMSO) Sigma - Aldrich D2650 
Dinatriumhydrogenphosphat Dihydrat Carl Roth GmbH & Co. KG 4984.2 
Disposable Scalpels Präzisa P. J. Dahlhausen & Co. GmbH 1100000722 
DNase I AppliChem Panreac A3778,0050 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) – high glucose 
Sigma - Aldrich D6429 
Ethanol Carl Roth GmbH & Co. KG K928 
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Ethylenediaminetetraacetic acid (EDTA) Carl Roth GmbH & Co. KG 8043.2 
F96 MaxiSorp Nunc-Immuno Plates VWR International 62409-024 
Fetal Bovine Serum (FBS) Sigma - Aldrich F7524 
Filter tip FT 1000 (G) (1000 µl) Greiner Bio-one 740288 
Filtropur S 0.2 Sarstedt AG & Co. 83.1826.001 
First Strand cDNA Synthesis Kit Thermo Fisher Scientific K1612 
Fluoromount-G® Southern Biotech 0100-01 
Formaldehyde Solution 5 % Otto Fischar GmbH & Co. KG 27261 
Glycerol Carl Roth GmbH & Co. KG 3783.2 
Glycine PUFFERAN Carl Roth GmbH & Co. KG 3908.3 
HEPES PUFFERAN Carl Roth GmbH & Co. KG 9105.4 
Horseradish Peroxidase (HRP) Sigma - Aldrich 77332 
Hydrochloric acid fuming 37% Carl Roth GmbH & Co. KG 4625.1 
Injekt® 20 ml B. Braun Melsungen AG 4606205V 
Ionic Detergent Compatibility Reagent 
(IDCR) 
Thermo Fisher Scientific 22663 
Isopropanol Carl Roth GmbH & Co. KG 6752.4 
Lactate Oxidase (LO) Sigma - Aldrich L0638 
Lactate Standard for IC – TraceCERT Sigma - Aldrich 07096 
Leupeptin-hemisulphate AppliChem GmbH A2183,0025 
Lipopolysaccharide (LPS) from E. coli 
serotype 055:B5 
Sigma - Aldrich L2880 
Magnesium chloride (MgCl2) Carl Roth GmbH & Co. KG HN03.1 
Maxima SYBR Green/ROX qPCR 
Master Mix (2X) 
Thermo Fisher Scientific K0221 
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Menzel-Gläser – Cover slips 
(24 x 32 mm) 
VWR International 631-0711 
Menzel-Gläser Superfrost – Microscope 
slides  (76 x 26 mm) 
Thermo Fisher Scientific AG00008032E 
Micro tube 1,5 mL Sarstedt AG & Co. 72.690.001 
Micro tube 1.5ml SafeSeal Sarstedt AG & Co. 72.706.400 
Micro tube 2,0 mL Sarstedt AG & Co. 72.691 
Micro tube 2.0ml SafeSeal Sarstedt AG & Co. 72.695.400 
Micro tubes 1.5 mL Sarstedt AG & Co. 72.690.001 
Mouse IL-10 ELISA kit BioLegend 431412 
Mouse IL-6 ELISA kit BioLegend 431302 
Mouse TNF-α ELISA kit BioLegend 430902 
N,N,N’,N’-Tetramethylethylenediamine 
(TEMED) 
Serva Electrophoresis 35930.02 
Nonylphenylpolyethylenglycol (NP)-40 Merck KGaA 492016 
Nunc-Immuno™ MicroWell™ 96-Well 
Plates, Thermo Scientific 
VWR International 442404 
PageRuler™ Prestained Protein Ladder Thermo Fisher Scientific 26616 
Paraformaldehyde Sigma Aldrich 158127 
Pasteur pipettes Karl Hecht "Assistent" GmbH 40567002 
Pefabloc SC (AEBSF hydrochloride) AppliChem A1412,0500 
Penicillin – Streptomycin  Sigma - Aldrich P0781 
Pepstatin A AppliChem A2205,0025 
Pierce 660nm Protein Assay Kit Thermo Fisher Scientific 22662 
Pipette tips (10 - 200 µL) Greiner Bio-one 739296 
Pipette tips (200 - 1000 µL) Greiner Bio-one 740290 
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Poly-L-Lysin Sigma - Aldrich P2636 
Potassium acetate Carl Roth GmbH & Co. KG 4986.1 
Potassium chloride (KCl) Carl Roth GmbH & Co. KG 6781.1 
Potassium dihydrogen phosphate 
(KH2PO4) 
Carl Roth GmbH & Co. KG 3904.1 
Potassium hydroxide (KOH) Fluka Chemie AG 60370 
Powdered milk Carl Roth GmbH & Co. KG T145.3 
Propidium iodide EMD Chemicals 537059 
QIAzol Lysis Reagent Qiagen 79306 
RNase Away Molecular BioProducts 7003 
Rotiphorese Gel 30  
(30% Acrylamide/bis-acrylamide 37.5:1)  
Carl Roth GmbH & Co. KG 3029.1 
SafeSeal SurPhob Filter tips (10 µl) Biozym Scientific GmbH VT0210 
Sapphire microplate 96 well for PCR Greiner Bio-one 652250 
Seahorse XF96 V3 PS Cell Culture 
Microplates 
Agilent Technologies  101085-004 
Sodium chloride (NaCl) Carl Roth GmbH & Co. KG 3957.2 
Sodium deoxycholate Sigma - Aldrich D6750 
Sodium dodecyl sulphate (SDS) Pellets Carl Roth GmbH & Co. KG CN30.3 
Sodium dodecyl sulphate (SDS) Sol. 20% AppliChem A3942,1000 
Sodium Hydroxide (NaOH) Sigma - Aldrich 9356.1 
Sodium orthovanadate Sigma - Aldrich S6508 
SurPhob Pipette tips (10µL) Biozym Scientific GmbH VT0110X 
TC Dish 100, Standard Sarstedt AG & Co. 83.3902 
TC Flask T75, Standard, Vent. Cap  Sarstedt AG & Co. 83.3911.002 
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Thiazolyl Blue Tetrazolium Bromide Sigma - Aldrich M5655 
TMB Substrate Set BioLegend 421101 
Transfer pipette 3.5 mL Sarstedt AG & Co. 86.1171 
Trichlormethan/ Chloroform Carl Roth GmbH & Co. KG 3313.1 
Tris ultrapure AppliChem A1086,5000 
Tubes, 15 mL Greiner Bio-one 188271 
Tubes, 50 mL Greiner Bio-one 227261 
Tween 20 Serva Electrophoresis 3747.0 
Western Lightning Plus-ECL, Enhanced 
Chemiluminescent Substrate 
PerkinElmer NEL104001EA 
Zymosan A (S. Cerevisiae) BioParticles, 
fluorescein conjugate 
Thermo Fisher Scientific Z2841 
β-1,3-(D)-glucan from C. Albicans 
Provided (and produced) by David Williams, East 
Tennessee State University, USA 
 
Table 3: Primary antibodies 
Antibody Vendor Cat. Number Application 
iNOS Abcam ab3523 Western blotting 
NFκB p65 (D14E12) Cell Signaling Technology 8242 Western blotting 
p100γ 
Institute for Molecular Cell Biology,   
Jena - Germany 
Western blotting 
P-NFκB p65 (S536) Cell Signaling Technology 3033 Western blotting 
Rel B Cell Signaling Technology 4954 Western blotting 
TNF-α Cell Signaling Technology 3707 Western blotting 
β-actin Sigma Aldrich 
A2228 
A5441 
Western blotting 
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Table 4: Secondary antibodies  
Antibody Vendor Type Dilution Application 
HRP- anti mouse KPL goat polyclonal 1:10.000 Western blotting 
HRP- anti rabbit KPL goat polyclonal 1:10.000 Western blotting 
 
Table 5: Antibodies for Immunohistochemistry 
Antibody Vendor Cat. Number Dilution 
Alexa Fluor® 568 
donkey anti-goat IgG  
Thermo Fisher Scientific A-11057 1:250 
Goat Iba-1 Abcam ab5076 1:250 
 
 
3.1.1. General buffers and solutions 
Phosphate-buffered saline (PBS) 
PBS (containing 8 g/L NaCl, 0,2 g/L KCl, 1,42 g/L Na2HPO4, 0,24 g/L KH2PO4) solved in 
double-distilled water (ddH2O) and the pH value has been adjusted to 7,5 and thereafter 
autoclaved. 
 
TE buffer 
All the primers (Table 6) were provided dry and ready for use upon resuspension with a weak 
buffer such as TE buffer (10 mM Tris, 1 mM EDTA, pH adjusted to 7,5) in a stock solution of 
100 μM and stored at -20°C. For real-time experiments a concentration of 10μM was suitable. 
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3.2. Methods 
 
3.2.1. Preparation and cell culture of primary microglial cells 
Primary microglial cells have been isolated from the brains of the newborn mice (P0-P3) from 
the following mice strains C57Bl/6J (wild type), PI3Kγ-/- (knock-out) and PI3KγKD/KD (knock-
in). The hippocampus has been removed and the brains from always two neonatal mice have 
been collected in a Falcon tube (15mL) together with the autoclaved PBS. PBS has been replaced 
with 2 mL dissociation medium (containing 20 mM HEPES, 0,05% Trypsin, 700 μM EDTA, and 
12 μg/mL DNase in DMEM) and incubated for 30 min at 37°C. Afterwards the mixed culture 
has been homogenized, added into a T75 Cell Culture flask with culture medium - DMEM 
complete (containing additionally 10% FCS heat-inactivated, 100 U/mL Penicillin, 100 μg/mL 
Streptomycin, 2,5 μg/mL Amphotericin B) and incubated for 14 days in the incubator (37 °C, 5% 
CO2). The culture medium has been changed once a week. 
Isolation of primary microglial cells have been done by using 2 mM EDTA (in autoclaved PBS) 
and gently shaking the flask so the microglial cells which are on the top have been collected in 
culture medium and astrocytes remain confluent on the bottom of the flask. Purity of microglia 
was always in the range between 95-98%, as confirmed by Iba1 staining (data not shown). All 
experiments were carried out in accordance with the German legislation on protection of animals 
and with permission of the local animal welfare committee (TWZ07-2017). 
 
3.2.2. Stimulation – “two hit” approach 
In order to induce adaptive (memory-like) response, microglial cells (75.000 cells/well) were 
seeded in a 12-well plate and were stimulated twice following a two-step (“two hit”) approach, 
consisting of initial priming with different doses of LPS (1 fg/mL – 100 ng/mL) or β-glucan (1 
fg/mL – 1 μg/mL) for 24h as described in Figure 3. Thereafter cells have been washed up and the 
medium has been changed. On day 6, microglial cells were re-stimulated with a fixed dose of 
LPS (100 ng/mL) or β-glucan (1 μg/mL). In parallel, we performed also control groups such as 
unstimulated (US) - without any stimulation, and unprimed (UP) - stimulated only on day 6 by 
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LPS or β-glucan. Samples have been collected in a period of 6h (RNA samples) and 24h (lysates 
and supernatants) after the 2
nd
 stimulation. 
 
Figure 3: Schematic view of the “two hit” approach to induce different adaptive response. 
Primary microglial cells (75.000 cells/well) were seeded on day 0 and stimulated with different doses of 
LPS (1 fg/mL – 100 ng/mL) or β-glucan (1 fg/mL – 1 μg/mL) on day 1 for 24h. On day 2 cells were 
washed up and followed by medium change on day 4. Thereafter cells were left to rest and on the day 6 
have been re-stimulated with a fixed dose of LPS (100 ng/mL) or β-glucan (1 μg/mL). 6h and 24h after 
the 2
nd
 stimulation samples have been collected and processed for further analyses. 
 
3.2.3. Enzyme-linked immunosorbent assay (ELISA) 
Cell culture media were assembled 24h after the second stimulation and centrifuged at 10.000 x 
g for 5 min at 4°C. Afterwards, the supernatants of each sample has been collected and 
immediately stored at -80°C for later to measure the cytokine production. Sandwich enzyme-
linked immunosorbent assay (ELISA) has been used to determine the levels of different pro-
inflammatory (TNF-α, IL-6) and anti-inflammatory (IL-10) cytokines. Different kits from 
BioLegend were used for this issue following the manufacturer instructions to run the assay 
(Table 2). First, 96 well Nunc-Immuno plates have been coated with coating buffer (8,4 g 
NaHCO3, 3,56 g Na2CO3, pH to 9,5) containing Capture Antibody (ratio 1:200) 1 day prior to 
running ELISA (at 4°C). 24h after the incubation time, plates have been washed thrice with 300 
μL/well wash buffer (PBS + 0,05% Tween-20) and incubated for 1h with 200 µL/well Assay 
Diluent (shaking) in order to block the non-specific binding and reduce the background. During 
this incubation time, standards and samples have been prepared and diluted using the assay 
diluent (1% BSA, filtered – 0,2 μm diameter) as required. Afterwards the plate has been washed 
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four times, followed by adding 100 µL/well of each standard and samples as duplicate in the 
appropriate wells and incubated for 2h (shaking). Again four times washing, and incubated with 
Detection antibody (100 µL/well, 1:200) in assay diluent for 1 hour. Then the plates have been 
washed again, followed by adding the enzyme Avidin-HRP (100 µL/well, 1:1000) diluted in 
assay diluent and incubated for 30 minutes with shaking (in the dark). After 30 minutes the 
plates have been washed five times and incubated (in the dark) with 100 µL/well TMB Substrate 
Solution until the desired blue color has been developed (15 - 30 minutes). In the end, the 
reaction (development of the color) was interrupted with stop solution by changing the pH and 
thus inactivating the enzyme (Avidin-HRP). 2N H2SO4 or 0,12N (1%) HCl are recommended for 
this issue. The absorbance was read at 450 nm with a second reference wavelength at 570 nm in 
VersaMax Microplate Reader (Molecular Devices, USA).  
Cytokine levels of TNF-α, IL-6 and IL-10 were normalized to the protein concentrations of each 
sample. 
 
3.2.4. SDS page and Western blotting 
Protein expression was analyzed by Western blotting of cell lysates 24h after the second 
stimulation. Briefly, cells were lysed using ice cold RIPA buffer (50 mM Tris-ultrapure, 150 mM 
NaCl, 1% NP-40, 0,5% Sodium deoxycholate, 0,1% SDS, pH adjusted to 8,0) to extract proteins 
from the cell culture samples. Prior to use, RIPA buffer has been supplemented freshly with the 
protease and phosphatase inhibitor cocktail (1 mg/mL Leupeptin ratio 1:500, 1 mg/mL Pepstatin 
A ratio 1:1000, 10 mM Na-orthovanadate ratio 1:500, 100 mg/mL Pefabloc ratio 1:1000) in 
order to prevent proteolytic degradation during cell lysis and protein extraction. Samples were 
centrifuged (13.500 x g for 30 min at 4°C), and supernatants were mixed with 5 x protein sample 
buffer - Lämmli buffer (33% Glycerol, 5% SDS, 25% 2-Mercaptoethanol, 0,1 mg/mL of 1% 
Bromophenol blue, 83 mM Tris, pH adjusted to 6,8) and heated for 5 min at 95°C.  
For the collection and separation gels the collection (0,5 M Tris-HCl, pH to 6,8) and separation 
buffers (2 M Tris-HCl, pH to 8,8) were used combined with 30% Acrylamide/bis-acrylamide, 
20% SDS, 20% APS and TEMED. Proteins were separated in 10% SDS- polyacrylamide gel 
electrophoresis (SDS-PAGE) buffer (25 mM Tris, 0,2 mM Glycine, 3,5 mM SDS) with a 
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constant 120 volt (V) and 30 milliampere (mA) per gel. Proteins have been transferred using 
Transfer buffer (48 mM Tris, 39 mM Glycine, 1,3 mM SDS, 15% Methanol) from the gel to a 
0,45 μm polyvinylidenfluoride (PVDF) membrane by a Semi-Dry-Blotting Machine (Millipore 
Graphite, Millipore USA) with a constant current (1 mA/cm
2
, 1h). Thereafter, the membrane was 
blocked with 1% BSA in TBS-T (50 mM NaCl, 0,1% Tween 20, 5 mM Tris-HCl, pH to 7,4) for 
30 min at room temperature (with shaking). Then the membrane was immunoblotted overnight at 
4°C (shaking) with primary antibodies mentioned above (Table 3), washed thrice with TBS-T 
(10 - 15 min/wash) and incubated with HRP-conjugated secondary antibody (1:10 000 in 1% 
BSA or 5% milk powder) for 1h at room temperature with shaking. Afterwards the membrane 
has been washed three times (5 min/wash) with TBS-T, and flushed with Western Lightning 
Plus-ECL Enhanced Chemiluminescent Substrate.  
Protein bands were detected by enhanced chemiluminescence reaction using LAS4000 camera 
(Fuji Photo Film Co., Tokyo, Japan). Quantification of the protein bands on the membrane was 
done using the FujiFilm Multi Gauge Ver. 3.0 software (Fuji Photo Film Co., Tokyo, Japan). 
 
3.2.5. Protein quantification 
Total protein concentration was determined using the Pierce™ 660 nm Protein Assay Kit 
(#22662) from Thermo Fisher Scientific (Massachusetts, USA). Ionic detergent compatibility 
reagent (IDCR) (#22663, Thermo Fischer Scientific) has been added to the Protein Assay 
Reagent prior to use in order to increase the detergent compatibility and reduce the interference. 
For the assay 10 μL of each replicate sample, standard and blank were added into a 96 well/plate, 
followed by 150 μL of the above mentioned protein assay reagent (containing IDCR) per well 
and incubated for 1 minute with shaking. Furthermore the plate has been incubated at room 
temperature for 5 minutes without shaking it. Then, absorbance was measured at 660 nm using 
TECAN Infinite 200 Plate reader (Tecan, Switzerland). Protein concentration is then calculated 
based on the values of the standard curve. 
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3.2.6. Seahorse assay and crystal violet staining  
Metabolic flux analysis was performed using a Seahorse XF96 Extracellular Flux Analyzer 
(Agilent technologies). 20.000 primary microglial cells were seeded on 96-well Seahorse XF96 
microplates. Cells were treated as described above (“two hit” approach). Before the experiment, 
supernatant medium was replaced with Seahorse XF Assay Medium (Agilent Technologies, pH 
adjusted to 7,4), supplemented with 10 mM D-glucose and 1 mM sodium pyruvate. Cells were 
then incubated for additional 1h in a CO2-free incubator at 37°C. Basal oxygen consumption rate 
(OCR) and extracellular acidification rate (ECAR) were measured before adding 2 µM 
oligomycin (Abcam), 30 µM 2,4-dinitrophenol and 2 µM antimycin A (Sigma). Each compound 
was injected consecutively. OCR and ECAR were measured as pmoles/min and mpH/min 
respectively, in cycles of 3 min mix and 3 min measure periods at 37°C. At the end of the 
measurement cells densities per well were quantified by crystal violet staining. The observed 
OCR and ECAR were normalized to corresponding cell densities. Wave software (Agilent 
Technologies) was used to analyze the data sets. After fixation for 10 min in 100% methanol at 
room temperature (RT), cells were incubated for 30 min at 37°C in a 0.05% crystal violet 
solution (in H2O). Following, cells were washed two times with H2O and cell bound crystal 
violet was resolved in 10% acetic acid whilst shaking on an orbital shaker. The resulting 
absorption was measured on an Infinite® M1000 PRO microplate reader (Tecan). 
 
3.2.7. Measurement of reactive oxygen species (ROS) 
Reactive oxygen species were measured using the H2DCFDA-assay. The assay is based on the 
use of 2’, 7’-Dichlordihydrofluorescein-diacetat (H2DCFDA; #D399, Thermo Fisher Scientific, 
Waltham, MA, USA), a membrane-permeable reduced form of fluorescein which reacts with 
reactive oxygen species, and then turning fluorescent. Therefore, microglial cells were seeded 
into white clear bottom 96-well plates (30.000 cells/ well). After becoming adherent, cells were 
stimulated twice with LPS, as described above. 24h after the second stimulation the medium was 
aspirated and 200 µl of H2DCFDA-solution (stock 50 mM 1:1000 in 10 mM HEPES/CaCl2) was 
added and cells were incubated for 20 min at 37°C. Thereafter, cells were carefully washed twice 
with an HEPES/CaCl2 solution. Measurement of intracellular ROS levels was performed at 485 
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nm excitation and 535 nm emission using TECAN Infinite 200 Plate reader (Tecan, 
Switzerland). 
 
3.2.8. Lactate production measurements 
Supernatants from microglial culture were used to measure lactate production by sequential 
enzymatic reactions, according to (Lin et al. 1999). First, lactate oxidase (LO; #L0638, Sigma-
Aldrich) converts lactate and oxygen to pyruvate and H2O2. In the second reaction, catalyzed by 
the horseradish peroxidase (HRP; #77332, Sigma-Aldrich), in the presence of H2O2, the 
chromogenic substrate ABTS (#A1888, Sigma-Aldrich) produces a colored dye which can be 
measured with a spectrophotometer at 405 nm. Lactate concentration has been calculated from a 
standard curve of known concentration of lactate (Lactate Standard for IC – TraceCERT; 
#07096, Sigma-Aldrich). Lactate levels were normalized to the protein concentrations of each 
sample. 
 
3.2.9. cAMP measurements 
Primary microglial cells (5.000 cells/well) have been seeded in 96 well/plates (clear-bottom) 
and treated as described above (“two hit” protocol). 24h after the 2nd stimulation, cyclic AMP 
production has been measured using cAMP GloAssayKit (#V1501, Promega) following 
manufactory’s protocol. Measurement of the luminescence was performed using TECAN 
Infinite 200 Plate reader (Tecan, Switzerland), and the cAMP values have been calculated based 
on the values of the standard curve. 
 
3.2.10.  In vitro phagocytosis assay 
Phagocytic efficiency has been investigated as described (Sun et al. 2008). Microglial cells 
(75.000 cells/ well) were seeded on cover slips in 12 well/plates and treated as described above 
(Fig. 3). 2 μL FITC labeled Zymosan A (S. cerevisiae) Bio Particles (9800U/mL) (#Z2841, 
Thermo Fischer Scientific) per 75.000 cells have been used to perform the phagocytosis assay. 
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After 1h incubation with Zymosan A at 37°C (5% CO2) cells were fixed with 500 μL/well 
Formalin 5%, washed three times with 2% NDS (in 1 x PBS) and blocked with 500 μL/well 10% 
NDS in PBS-Tween 0.1%. Cells were first incubated with 300 μL/well Iba1 primary antibody 
(goat Iba1, #ab5076, Abcam) for 1h at room-temperature, thereafter washed with 1 x PBS and 
incubated with 300 μL/well secondary antibody (Alexa Fluor® 568 donkey anti goat IgG). Cells 
then were stained with DAPI-solution for 10 min (2 μg/mL, ratio 1:1000 in 1 x PBS) and washed 
four times with PBS. Cover slips (24 x 32 mm) then were mounted with Fluoromount-G (#0100-
01, Southern Biotech) into microscope slides. Phagocytosed particles and cells of five 
independent visual fields were counted under a fluorescence microscope. The result of the 
phagocytosis was calculated by determining the phagocytic index (the uptake rate of FITC-
Zymosan particles per cell). 
 
3.2.11.  In vivo phagocytosis assay 
Experiments were performed on adult (10–14 weeks) WT, PI3Kγ-/- and PI3KγKD/KD mice (7 mice 
per group) kept at neutral ambient temperature (T=30°C) during the whole experimental period. 
According to the “two hit” approach, mice were initially injected with either low dose LPS 
(0.025 mg/kg, i.p.) or high dose LPS (10 mg/kg, i.p.) for priming and 3 days later with a 
subsequent application of 10 mg/kg, i.p. LPS. Administration of fluorescein isothiocyanate 
(FITC)-labeled Zymosan particles (9800U/mL) were performed 24 hours after the second LPS 
injection as described previously (Schmidt et al. 2013). Mice were anesthetized by 
intraperitoneal injection of ketamine (100 mg/kg) and xylazine (16 mg/kg), and were positioned 
in a stereotaxic apparatus (Stoelting, Wood Dale, IL, USA). Mice were then placed on a 
homoeothermic heat blanket to maintain normal body temperature during surgery. The skull was 
exposed by a skin incision, and small burr holes were drilled through the skull. Using a 
micromanipulator cannula (diameter 0,24 mm) attached on a Hamilton micro syringe (0,5 µL) 
was stereotaxically placed into the thalamus on both sides (stereotaxic coordinates were AP: 2,0 
mm; L: ± 1,5 mm; and V: 2,0 mm). Subsequently, 20 nL of FITC-labeled Zymosan particles 
suspended in artificial cerebrospinal fluid were infused within 120 sec. The cannula remained in 
place for 5 min before removal. 24h later mice were deeply anesthetized and perfused with 4% 
paraformaldehyde (PFA) in phosphate buffer by cardiac puncture via the left ventricle.  
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Brains were removed immediately after fixation and post-fixed for 5h in 4% PFA at 4°C. After 
cryoprotection in PBS containing 30% sucrose, brains were frozen in methyl butane at -30°C and 
stored at -80°C. Whole brains were cut by coronal sections at 40 µm on a freezing microtome 
(Microm International GmbH, Thermo Scientific, Germany). The slices were immuno-stained 
with anti-Iba1 antibody to visualize microglia. An altitude of 40 µm was predefined as region of 
interest. Z-stack imaging was performed with a 20x objective using fluorescence microscope 
(Nikon Eclipse Ti, Nikon Instruments - Japan). Quantitative measurements were done using 
ImageJ software (NIH, Bethesda, MD), blinded to the treatment groups were used to count the 
percentage number of Iba-1 positive cells per voxel mm
3
 containing Zymosan particles. 
 
3.2.12.  Blood plasma and brain tissue cytokine measurements 
Cytokines levels of TNF-α and IL-6 in blood plasma and brain tissue were determined following 
the manufacturer instructions using BioLegend kits as shown previously (Table 2). Briefly, blood 
samples were collected in heparin coated tubes (1,5 mL) by the heparinized needles and 
centrifuged for 10 min at room temperature at 2.000 x g, followed by collecting in the new tubes 
the blood plasma and stored at -80°C. The brain tissue was harvested after rinsing with cold 
PBS, immediately put in ice cold methyl butane and kept at -80°C until processing. The brain 
tissue was then powdered in homogenization buffer (50 mM Tris, 150 mM NaCl, 5 mM EDTA; 
pH to 8,0) containing phosphatase and protease inhibitors, and then centrifuged at 10.000 x g for 
10 min at 4°C and supernatant were stored at -80°C until the measurement. Cytokine production 
data were normalized to the protein concentrations of each sample.  
 
3.2.13. RNA isolation and real-time PCR 
6 hours after the 2
nd
 hit, media has been removed and further preceded to RNA isolation. To 
determine gene expression levels, total RNA was extracted using 0,5 mL QIAzol Lysis Reagent 
(#79306) purchased from Qiagen (Hilden, Germany), followed by 0,2 mL chloroform into 2 mL 
tubes and centrifuged at 12.000 x g for 15 min at 4°C. After the centrifugation, the colorless 
upper phase was collected in new 1,5 mL tubes and further proceeded to the RNA precipitation 
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procedure by using 0,5 mL of 100% isopropanol (propanol-2) (incubated at RT for 10 min). 
Samples were centrifuged at 12.000 x g for 10 min at 4°C and processed to the RNA wash step, 
where the upper phase has been removed leaving only the RNA pellet. The pellet was washed 
with 1 mL 75% ethanol, centrifuged again (7.500 x g, 5 min at 4°C) and left for 10 - 15 minutes 
to air dry the pellet. Then the pellet was dissolved in 40 μL RNase - free water (PCR water) and 
stored at -80°C. RNase Away solution was used to flush pipettes and other equipments in order 
to prevent any contamination with other RNases or DNAs. RNA concentration and quality were 
checked using the Nanodrop ND-1000 machine (Peqlab, Erlangen, Germany). Complementary 
DNA (cDNA) was synthesized using RevertAid First Strand cDNA Synthesis kit (#K1612) from 
Thermo Fisher Scientific (Waltham, MA, USA). Real-time qPCR reaction was performed using 
Realplex Mastercycler EpGradient S (Eppendorf AG, Germany). Primers were prepared using 1 
x TE buffer and used in a concentration of 10 μM as depicted in Table 6. GAPDH was used as 
housekeeping gene for normalization of the target genes. Relative gene expression was 
calculated using the comparative CT (      ) method (Schmittgen and Livak 2008). 
Table 6: Primers used for real-time PCR 
Genes Forward primer (5’-3’) Reverse primer (5’-3’) 
GAPDH CATGGCCTTCCGTGTTTCCTA CCTGCTTCACCACCTTCTTGAT 
HIF-1α CTCATCAGTTGCCACTTCC TCATCTTCACTGTCTAGACCAC 
IL-10 ACCAGCTGGACAACATACTGC TCACTCTTCACCTGCTCCACT 
IL-6 CCTCTCTGCAAGAGACTTCCATCCA GGCCGTGGTTGTCACCAGCA 
iNOS AAGGCCACATCGGATTTCAC GATGGACCCCAAGCAATACTT 
MyD88 TCCGGCAACTAGAACAGACAGACT GCGGCGACACCTTTTCTCAAT 
TLR4 ACCTGGCTGGTTTACACGTC CAGGCTGTTTGTTCCCAAAT 
PFKFB3 GGAGAGGTCAGAGGATGCAAA GCTGTTGATGCGAGGCTTTT 
TNF-α CTGTAGCCCACGTCGTAGC TTGAGATCCATGCCGTTG 
TRIF CACAGTCCCAATCCTTTC TCACTCTGGAGTCTCAAG 
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3.2.14. Statistical analysis 
Graphs were prepared using GraphPad Prism6 software (GraphPad Software, La Jolla, CA, 
USA), and statistical analysis were carried out using SigmaPlot Software (SigmaPlot Software, 
San Jose, USA). Data are presented as box plots showing the medians with the boxes ranging 
from 25
th
 -75
th
 percentile and whiskers ranking form 10
th
 to 90
th
 percentiles (extreme data are 
marked outside). Comparisons between groups were made with one or two-way analysis of 
variance (ANOVA), followed by Holm-Sidak post-hoc test. Differences were considered 
significant when P<0.05, where * indicates differences vs. unprimed state, and § indicates 
differences vs. cells obtained from wild-type mice. 
Grubbs’ test has been used to remove extreme outliners in order to show reasonable data 
analysis. 
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IV. Results 
 
4.1. LPS and β-glucan induce dose-dependent adaptive responses in primary microglial 
cells 
4.1.1. Paradigmatic analysis of priming effects resulting from incremental increase of 
stressor concentration 
The primary aim of this project was to investigate the ability of the microglia to induce trained 
sensitization and tolerance after subsequent challenge with different stressors. Initially, single 
stimulations with different doses of LPS, starting from 1 fg/mL up to 100 ng/mL LPS, affected 
the production of pro-inflammatory cytokines (TNF-α, IL-6) in a dose-dependent manner, where 
increasing doses of LPS (˃100 pg/mL) significantly enhanced the levels of cytokine release in 
primary microglial cells (Fig. 4). 
 
Figure 4: Production levels of TNF-α and IL-6 after single stimulation with different doses of LPS. 
Primary microglial cells were stimulated with different doses of LPS, starting from 1 fg/mL – 100 ng/mL 
for 24 hours. Supernatants were collected and the cytokine levels for: A) TNF-α, B) IL-6 have been 
assayed by ELISA. Data are shown as boxplots and whiskers, *p <0.05, * vs. unstimulated condition, 1-
way-ANOVA (Holm-Sidak post-test). 
 
In order to induce adaptive responses, a so called “two hit” approach was used as described 
above (see 3.2.2.). Gene expressions and protein expression of iNOS as well as TNF-α release 
were assayed by real-time PCR, western blotting and ELISA. Results show that low doses 
primed primary microglial cells, especially at 1 fg/mL LPS show significantly increased levels of 
TNF-α known as trained sensitization, whereas cells primed with higher doses of LPS exhibited 
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tolerance behavior exemplified by decreased levels of TNF-α compared to the unprimed state 
(Fig. 5A-C, E). 
 
Figure 5: LPS induces trained sensitization and tolerance in a dose-dependent manner in primary 
microglial cells primed with different doses of LPS after subsequent re-stimulation. 
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Microglial cells have been primed with increasing doses of LPS (1 fg/mL – 100 ng/mL) on day 1 and re-
stimulated with 100 ng/mL LPS on day 6. RNA samples (6h), lysates and supernatants (24h) have been 
collected after the 2
nd
 stimulation and analyzed for TNF-α by: A) real-time PCR (normalized to GAPDH 
and are relative to unprimed state (assigned as 1.0)), B) ELISA immuno-assay (normalized to total protein 
concentration) and C) Western blot and quantified values (E). iNOS protein expression and quantification 
have been assayed by Western blotting (D, F), whereas ROS was assayed using H2DCFDA-oxidation (G). 
Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition (grey column), 2-way-
ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
We further investigated the protein expression of inducible NO synthase (iNOS) as inflammatory 
mediator, important for NO production in microglial cells. As shown in Fig. 5D, F, iNOS 
expression was significantly increased in microglial cells primed with 1 fg/mL LPS indicating 
trained sensitization, whereas increasing doses, especially at 100 ng/mL LPS induced a strong 
reduction of the iNOS expression indicating trained tolerance. In addition, ROS production was 
similarly altered, e.g. an enhanced ROS production has been verified in microglial cells primed 
with low-dose LPS as well as diminished levels after priming with higher LPS doses (Fig. 5G). 
In order to verify PAMP species-independent priming effects, the fungal PAMP β-glucan was 
used. As shown in Fig. 6A microglial cells have been stimulated with increasing doses, from 1 
fg/mL up to 1 μg/mL of β-glucan. Data show that β-glucan did not provoke any changes in the 
TNF-α production with increasing doses, except in the highest β-glucan dose used. In addition, in 
order to answer the question if β-glucan priming of primary microglial cells in vitro can lead to 
similar dose-dependent adaptive responses as priming with LPS, we re-challenged the cells with 
a fixed concentration of LPS (100 ng/mL). As shown in Fig. 6B, microglial cells primed with 0.1 
pg/ml β-glucan exhibited trained sensitization characterized by increased TNF-α levels compared 
to the unprimed state, whereas doses equal or higher than 100 pg/mL, exclusively the highest 
dose of β-glucan (1 μg/mL) lead to decreased production of TNF-α in microglial cells. 
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Figure 6: β-glucan induces dose-dependent adaptive responses, trained sensitization at low doses 
and tolerance in higher concentrations, after re-challenge with LPS. 
(A) Single dose response with β-glucan shows no significant alterations in TNF-α production, expect 1 
μg/mL which shows increasing amounts. Microglial cells stimulated using the “two hit” approach, primed 
with different doses of β-glucan, are capable to induce increasing levels of TNF-α (B) at 100 fg/mL, 
whereas higher doses, notably 1 μg/mL suppress the production of TNF-α. Data are shown as boxplots 
and whiskers, *p <0.05, * vs. unstimulated condition (grey columns) (A), 1-way-ANOVA (Holm-Sidak 
post-test); and *p <0.05, * vs unprimed condition (grey column) (B), 2-way-ANOVA (Holm-Sidak post-
test). US, unstimulated; UP, unprimed. 
 
As shown above, microglial cells primed with β-glucan were re-challenged with 100 ng/mL LPS, 
raising the question if β-glucan (1 μg/mL) re-stimulation can induce similar adaptive responses. 
Microglial cells were primed with β-glucan and re-challenged again with β-glucan (1 μg/mL).  
 
Figure 7: TNF-α production after subsequent stimulation with the same stressor, β-glucan. 
Single stimulation triggers enhanced production of TNF-α at 1 μg/mL (A), re-challenge of the microglial 
cells with β-glucan leads to similar adaptive responses, with enhanced levels at 100 fg/mL and decreased 
levels at 1 μg/mL (B) of TNF-α measured by ELISA immuno-assay. Data are shown as boxplots and 
whiskers, (A) *p <0.05, * vs. unstimulated condition, 1-way-ANOVA (Holm-Sidak post-test); and (B) 
*p<0.05, * vs. unprimed condition, 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, 
unprimed. 
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Results showed that priming with 100 fg/mL β-glucan induces increased levels of TNF-α, 
whereas the concentration of 1 μg/mL reduces significantly the production of TNF-α after 
subsequent challenge (Fig. 7). Altogether our data indicate that different PAMPs (LPS and β-
glucan) are able to induce trained sensitization when primed with very low PAMPs doses, 
whereas microglial cells primed with high PAMPs doses lead to reduced levels of the 
inflammatory mediators indicating tolerance behavior. 
 
4.1.2. Identification of priming effects upon various pro- and anti-inflammatory 
responses in microglial cells 
Based on the data resulting from incremental increase of stressor concentrations presented in 
4.1.1., we decided to focus further studies on trained sensitization and tolerance using stressor 
concentrations with maximum priming effects (trained sensitization: LPS: 10
-3
 pg/mL, β-glucan: 
10
-1
 pg/mL; trained tolerance: LPS: 10
5
 pg/mL, β-glucan: 106 pg/mL). 
First, additional indicators for pro-inflammatory microglial response were studied. As shown in 
Fig. 8, overall microglial response after priming and re-stimulation regarding IL-6 production 
was similar as for TNF-α production, e.g. microglial cells primed with 1 fg/mL LPS exhibited 
trained sensitization after subsequent challenge, whereas cells primed with 100 ng/mL showed 
after re-stimulation reduced levels of IL-6 known as tolerance response. 
 
Figure 8: IL-6 production in primary microglial cells after priming and subsequent stimulation by 
LPS. 
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Microglial cells have been primed with two different doses of LPS (1 fg/mL and 100 ng/mL) on day 1 
and re-stimulated with 100 ng/mL LPS on day 6. RNA samples (6h) and supernatants (24h) have been 
collected after the 2
nd
 hit and analyzed for IL-6 using: A) real-time PCR (normalized to GAPDH and are 
relative to unprimed state (assigned as 1.0)), and B) ELISA immuno-assay (normalized to total protein 
concentration). Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition (grey 
column), 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
Furthermore, microglial cells primed with β-glucan displayed similar adaptive dose-response, 
e.g. an increased production of IL-6 by priming with 100 fg/mL β-glucan and decreased levels of 
IL-6 by priming with 1 μg/mL β-glucan (Fig. 9). 
 
Figure 9: IL-6 production amounts of microglial cells after priming with different doses of β-glucan 
and subsequent stimulation by LPS. 
Microglial cells stimulated using the “two hit” approach, primed with different doses of β-glucan (100 
fg/mL and 1 μg/mL), induce increasing levels of IL-6 at 100 fg/mL, whereas 1 μg/mL suppresses the 
production of IL-6. Data are shown as boxplots and whiskers, *p <0.05, * vs. unstimulated condition 
(grey column), 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
In order to confirm the above findings about iNOS protein levels, we analyzed the messenger 
RNA (mRNA) expression of iNOS and found also that after priming with 1 fg/mL LPS the iNOS 
expression was up-regulated, whereas priming with 100 ng/mL LPS led to a down-regulation in 
primed microglial cells after subsequent LPS challenge (Fig. 10A). A similar response pattern 
was shown for gene expression of HIF-1α (Fig. 10B). 
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Figure 10: Increased mRNA levels of iNOS and HIF-1α indicating trained sensitization after low-
dose priming of microglial cells and down-regulation indicating tolerance response in microglial 
cells after high-dose priming with LPS. 
Gene expression was analyzed by real-time PCR using cDNA samples of the targeted RNA samples: A) 
iNOS and B) HIF-1α. Cells have been stimulated using a “two hit” approach: priming with different doses 
(1 fg/mL – 100 ng/mL) and on day 6 re-challenging them with a fixed dose (100 ng/mL) LPS. Data are 
shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition, 2-way-ANOVA (Holm-Sidak post-
test). US, unstimulated; UP, unprimed. 
 
Therefore, microglial cells are able to induce trained sensitization as response to low-dose 
priming with LPS, mainly characterized with increased expression of different pro-inflammatory 
mediators similar to a “M1”-like phenotype of microglia. Moreover, cells after high-dose 
priming develop tolerance behavior characterized with decreased levels of pro-inflammatory 
mediators.  
To further investigate additional features of tolerance behavior of microglial cells, we evaluated 
also the expression and production of the anti-inflammatory mediators such as Arg-1, IL-10, IL-
4, and TGF-β. As anticipated, high-dose primed microglial cells that induce a tolerant response, 
displayed increased levels of the anti-inflammatory mediators at the gene regulatory as well as 
protein expression level, corresponding to the so called “M2”-like phenotype (Fig. 11). 
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Figure 11: Increased anti-inflammatory markers during tolerance in primary microglial cells. 
Primary cells have been stimulated using the “two hit” approach. Priming with 100 ng/mL LPS triggers 
increased expression of IL-10 (A), TGF-β (C), Arg-1 (D) and IL-4 (E) measured by real-time PCR, data 
are normalized to GAPDH representing relative values to unprimed state (assigned as 1.0). Moreover the 
production of the anti-inflammatory cytokine IL-10 has been enhanced as well in the primary microglial 
cells pre-stimulated with 100 ng/mL LPS, assayed by ELISA immuno-assay and normalized to protein 
levels. Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition (grey column), 2-
way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
Since trained sensitization and tolerance responses are characterized also by different metabolic 
states, we investigated the lactate production in primary microglial cells, as an indirect parameter 
to verify the glycolytic activity of cells. Our data showed that low-dose primed microglial cells 
exhibited an increased lactate production, whereas high-dose primed microglial cells showed 
decreased levels of lactate (Fig. 12).  
In addition we analyzed the gene expression of the 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3 (PFKFB3), a gene associated with glycolysis and found that there was a partly 
similar response as shown for lactate production, e.g. an enhanced expression after low-dose 
priming (Fig. 12). 
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Figure 12: Increasing glycolysis during trained sensitization showed by increased lactate 
production and PFKFB3 expression. 
The “two-hit” approach has been used to stimulate primary microglial cells. Lactate production (A) has 
been measured by sequential enzymatic reactions (see 3.2.8.). PFKFB3 expression has been assayed using 
real-time PCR and the data are normalized to GAPDH representing relative values to unprimed state 
(assigned as 1.0). Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition (grey 
column), 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
Therefore, primary microglial cells in vitro are capable to respond with opposed adaptive 
patterns, trained sensitization with low-dose priming and tolerance (persistence) behavior owing 
to high-dose priming with different PAMPs.  
 
4.2. PI3Kγ regulates cytokine production during trained sensitization and tolerance 
Considering the above findings that microglia are capable to induce adaptive responses in a dose-
dependent manner- trained sensitization at 1 fg/mL and tolerance at 100 ng/mL LPS, in addition 
to our group data about PI3Kγ, we hypothesized that PI3Kγ has a crucial role mediating trained 
sensitization and tolerance in microglial cells. Since one of the key characteristics of the trained 
sensitization was increased production of pro-inflammatory cytokines, whereas during tolerance 
that inflammatory response was significantly decreased, in addition to increased anti-
inflammatory activity, we decided to investigate the role of PI3Kγ controlling the cytokine 
profile in primary microglial cells in vitro.  
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Figure 13: Lipid kinase-dependent function of PI3Kγ controlling the cytokine production during 
trained sensitization and tolerance induced by sequential challenge with LPS. 
Microglial cells were stimulated using the “two hit” approach, priming with 1 fg/mL or 100 ng/mL LPS, 
and re-stimulated with 100 ng/mL LPS. Low-dose LPS induces increased production of pro-inflammatory 
cytokines, TNF-α (A) and IL-6 (B), on wild-type microglial cells, whereas knock-out (PI3Kγ-/-) and 
kinase-dead (PI3KγKD/KD) show attenuated levels and significant differences with wild-type cells. High-
dose priming with LPS (100 ng/mL) induced decreased TNF-α (A) and IL-6 (B) release. Furthermore 
primary microglial cells derived from knock-out and kinase-dead mice showed a more reduced 
production of cytokines under consideration compared with wild-type microglia. The production of IL-10 
(C) has mainly been affected after high-dose priming, where wild-type microglia showed increased levels 
of the anti-inflammatory cytokine, distinct from PI3Kγ-/- and PI3KγKD/KD that do not show any significant 
changes. Cytokine production was measured using ELISA immuno-assay (normalized to the total protein 
concentrations). Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition and §p 
<0.05, § vs. wild-type strain, 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
The role of PI3Kγ regulating the cytokine profile during trained sensitization and tolerance 
response up to date remained unknown. In order to answer this issue we performed experiments 
using primary microglial cells originated from newborn mice (P0-P3; 1 to 3 days old mice) from 
the following mice strains: C57Bl/6J (wild type), PI3Kγ-/- (knock-out) and PI3KγKD/KD (knock-
in). Microglial cells isolated from those different strains have been stimulated using the “two hit” 
approach, performed as described above (see 3.2.2.). Our data show that PI3Kγ controls the 
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production of pro-inflammatory (TNF-α, IL-6) and anti-inflammatory (IL-10) cytokines during 
the adaptive responses in primary microglial cells (Fig. 13). Wild-type cells primed with 1 fg/mL 
and subsequently challenged with 100 ng/mL showed increased production of TNF-α and IL-6 
compared to the two other strains (PI3Kγ-/- and PI3KγKD/KD), where just wild-type microglia 
were able to develop trained sensitization at 1 fg/mL compared to their unprimed state. 
Microglial cells primed with 100 ng/mL LPS released enhanced levels of IL-10 production in 
wild-type cells compared to PI3Kγ-/- and PI3KγKD/KD. Furthermore, solely wild-type cells were 
able to release increased production of the anti-inflammatory cytokine, IL-10, compared with the 
unprimed condition.  
These results confirm that lipid kinase-dependent activity of PI3Kγ comprised the key regulator 
function for cytokine profiling at trained sensitization and tolerance, representing a crucial role in 
controlling these adaptive responses in microglial cells. 
 
4.3. Cytokine production is regulated by TLR4/MyD88-dependent pathway of NFκB 
activation mediated by PI3Kγ 
In order to explore possible molecular mechanisms responsible for increased TNF-α and IL-6 
production in wild-type cells primed with 1 fg/mL and for the enhanced production of IL-10 by 
the microglial cells primed with 100 ng/mL LPS compared to unprimed state and PI3Kγ mutants, 
we first analyzed the protein levels of p110γ (Fig. 14). 
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Figure 14: p110γ protein expression in primary microglial cells after priming and subsequent 
stimulation by LPS. 
Primary microglial cells were stimulated as noted above (see 3.2.2.), lysates were analyzed by western 
blotting technique. Note the increased expression of p110γ in wild-type cells primed with 1 fg/mL LPS, 
whereas the same condition doesn’t show any significant differences in kinase-dead microglial cells 
compared to unprimed state. Moreover there was increased expression of p110γ in the wild-type cells 
compared to the kinase-dead cells primed with 1 fg/mL LPS. Data are shown as boxplots and whiskers, 
*p <0.05, * vs. unprimed condition and §p <0.05, § vs. wild-type strain, 2-way-ANOVA (Holm-Sidak 
post-test). US, unstimulated; UP, unprimed. 
 
Our data showed that p110γ expression is increased in wild-type microglial cells after priming 
with 1 fg/mL compared to the unprimed state and thus related with increased levels of pro-
inflammatory cytokine (TNF-α, IL-6) production, whereas PI3KγKD/KD microglial cells didn’t 
show any significant expression levels of p110γ compared to unprimed cells. Moreover, wild-
type microglial cells primed with 1 fg/mL LPS showed increased levels of p110γ compared to 
the same condition in the PI3KγKD/KD cells.  
Since NFκB activation is one of the main processes for the cytokine production, we further 
decided to investigate the protein expression of p65 (Rel A), known to regulate the production of 
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the inflammatory cytokines in different cells. To answer this issue we analyzed the expression of 
p65 in microglial cells obtained from wild-type, PI3Kγ-/- and PI3KγKD/KD mice (Fig. 15). 
 
Figure 15: Protein expression of p65 (Rel A) in primary microglial cells after priming and 
subsequent challenge with LPS. 
Microglial cells isolated from different genotypes (wild-type, PI3Kγ-/- and PI3KγKD/KD) were stimulated 
using the “two hit” approach as mentioned above, and the lysates have been measured by western blotting 
method. Note the increased expression of p65 (Rel A) in wild-type cells primed with 1 fg/mL, whereas 
the same condition showed decreased levels of p65 in the PI3Kγ-/- and PI3KγKD/KD cells compared to 
unprimed condition. Microglial cells primed with 100 ng/mL LPS show decreased protein expression of 
p65 in PI3Kγ-/- and PI3KγKD/KD cells after second LPS challenge compared to the unprimed state. 
Furthermore wild-type cells show significantly higher expression of p65 compared to other genotypes 
(PI3Kγ-/- and PI3KγKD/KD). Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition 
and §p <0.05, § vs. wild-type strain, 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, 
unprimed. 
 
Our results revealed that p65 expression in wild-type cells primed with the low-dose LPS  
express higher levels of the phosphorylated form of p65, whereas PI3Kγ-/- and PI3KγKD/KD 
microglial cells display reduced expression compared to the unprimed state. PI3Kγ-/- and 
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PI3KγKD/KD cells primed with high-dose LPS showed decreased levels of the phosphorylated p65 
compared to the unprimed state. Moreover wild-type cells displayed increasing protein levels of 
phosphorylated p65 for both of priming doses, compared with PI3Kγ-/- and PI3KγKD/KD cells 
(Fig. 15).  
Another member of the NFκB family, Rel B, was reported to suppress the cytokine release of the 
pro-inflammatory cytokines such as TNF-α and IL-6. In order to investigate the role of Rel B in 
primary microglial cells after priming and subsequent challenge with LPS, we analyzed the 
protein expression (Fig. 16).   
 
Figure 16: Rel B protein expression in primary microglial cells after priming and subsequent 
stimulation with LPS. 
Wild-type, PI3Kγ-/- and PI3KγKD/KD microglial cells were stimulated using the “two hit” approach as 
mentioned above. Lysates have been analyzed by western blotting. Note the increased protein expression 
of Rel B in the PI3Kγ-/- cells primed with 1 fg/mL and 100 ng/mL LPS, compared to the wild-type 
microglia. Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition and §p <0.05, § 
vs. wild-type strain, 2-way-ANOVA (Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
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Data revealed that PI3Kγ-/- microglial cells primed with low and high LPS doses showed 
increased levels of protein expression for Rel B compared to wild-type genotype. Interestingly, 
for both priming doses wild-type cells showed a tendency for decreased protein expression levels 
of Rel B. 
These results showed that the cytokine profile is mainly regulated by the interplay between p65 
and Rel B activation, and is apparently regulated by PI3Kγ activity in primary microglial cells. 
Besides it remains to clarify, if the MyD88-dependent or -independent pathway mediates the 
adaptive response in microglial cells after priming and subsequent stimulation with LPS. In order 
to investigate this issue RNA samples were collected solely from wild-type cells since these cells 
were capable to induce both, trained sensitization and tolerance response. Therefore, mRNA 
levels of the TLR4 receptor and its different adaptor proteins MyD88 (MyD88-dependent) and 
TRIF (MyD88-independent) have been analyzed using real-time PCR (Fig. 17). 
 
Figure 17: Increased expression of TLR4 at trained sensitization, mediated by the MyD88-
dependent pathway, whereas at tolerance a decreased TLR4/MyD88 expression occurred. 
TLR4 and MyD88 gene expression was increased in wild-type microglial cells primed with low-dose 
LPS, whereas priming with high-dose LPS provoked down-regulation of TLR4/MyD88 after subsequent 
stimulation with LPS. Moreover, TRIF adaptor expression was not significantly affected. Real-time PCR 
data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition, 2-way-ANOVA (Holm-
Sidak post-test). US, unstimulated; UP, unprimed; mRNA, messenger RNA. 
 
The above data demonstrated that wild-type microglia primed with 1 fg/mL LPS, show increased 
mRNA expression of TLR4 as well as significant enhanced MyD88 adaptor expression. In 
contrast, microglial cells primed with 100 ng/mL LPS showed decreased levels of TLR4/MyD88 
expression. The mRNA expression levels of TRIF showed a slightly higher tendency compared 
to MyD88 at 100 ng/mL, but remained unchanged. Taken together, the above results show that 
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mainly the TLR4/MyD88-dependent pathway is activated in consequence of priming of 
microglial cells and subsequent re-challenge with LPS, which is transmitted by p65 and Rel B 
activation and regulated by the activity of PI3Kγ. 
 
4.4. Trained sensitization and tolerance are characterized by metabolic changes 
mediated by the lipid kinase-independent activity of PI3Kγ 
In the beginning it was reported that “memory-like” adaptive responses of the innate immune 
system are mainly induced by epigenetic modifications and regulated by metabolic changes. Our 
previous results have shown that lactate production is markedly increased as a result of trained 
sensitization and decreased in consequence of tolerance (Fig. 12). In order to investigate role and 
extent of metabolic changes related with trained sensitization and tolerance we performed 
measurements of cellular metabolism in microglial cells. This assay allowed us to analyze 
simultaneously in real-time the glycolytic activity and mitochondrial respiration in primary 
microglial cells. Furthermore, we investigated the basal – cells at starting assay conditions, as 
well as stressed - cells under an induced energy demand (specifically, in the presence of stressor 
compounds such as oligomycin, 2,4-dinitrophenol and antimycin A) phenotypes of OCR and 
ECAR. 
Measurement of oxygen consumption rates (OCR) revealed that microglial cells derived from 
PI3Kγ-/- mice exhibited an increased oxidative metabolism compared to wild-type cells (Fig. 18). 
Interestingly, wild-type microglia primed with 1 fg/mL LPS showed increased values of OCR 
compared to the unprimed state under baseline as well as under stressed condition. This was, 
different from the other two genotypes (PI3Kγ-/- and PI3KγKD/KD) under consideration. 
PI3KγKD/KD cells primed with 100 ng/mL LPS showed decreased OCR values under basal 
condition compared to wild-type cells. Moreover PI3Kγ-/- and PI3KγKD/KD cells primed with 100 
ng/mL LPS displayed significantly decreased baseline OCR levels compared to the unprimed 
state. These findings were different from wild-type cells that showed just a tendency of decline 
(Fig. 18). In summary the data showed that the scaffold function of PI3Kγ appears to be involved 
in regulating OCR in microglial cells. 
55 
 
 
Figure 18: Time-dependent effects on the oxygen consumption rates (OCR) in primary microglial 
cells after priming and subsequent stimulation with LPS. 
Cells have been seeded in 6 replicates per experiment and stimulated as mentioned before using the “two 
hit” approach, measured by the Seahorse assay. Overall the PI3Kγ-/- (B) genotype of the microglial cells 
showed enhanced levels of OCR compared to the wild-type (A) and PI3KγKD/KD (C) under baseline and 
stressed phenotype (D, E). Wild-type microglia primed with 1 fg/mL display increased oxygen 
consumption rates compared to UP state under baseline (D) as well as stressed (E) condition. PI3Kγ-/- and 
PI3KγKD/KD cells show significant decreased OCR values by priming with 100 ng/ml LPS (D, E). Data are 
normalized to the corresponding cell densities and shown as XY time-dependent graphs (A, B, C)  as well 
quantified and showed as boxplots and whiskers (D, E), *p <0.05, * vs. unprimed condition (2-way-
ANOVA) and §p <0.05, § vs. wild-type strain (1-way-ANOVA), Holm-Sidak post-test. US, unstimulated; 
UP, unprimed; OCR, oxygen consumption rates. 
 
Initially we showed that trained sensitization in microglial cells exhibits increased lactate 
production suggesting a glycolytic metabolic state. In order to verify that findings the 
extracellular acidification rates (ECAR) were analyzed. Our results showed that ECAR studied 
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under stressed conditions exhibited that wild-type microglial cells primed with 1 fg/mL LPS 
showed significantly enhanced levels of ECAR (Fig. 19). In contrast, PI3Kγ-/- and PI3KγKD/KD 
microglial cells primed with 100 ng/mL LPS display significantly decreased levels of baseline 
ECAR. Furthermore PI3Kγ-/- cells showed increased ECAR values just under stressed conditions 
compared to wild-type cells (except under priming with 1 fg/mL).  
 
Figure 19: Time-dependent effects on the extracellular acidification rates (ECAR) in primary 
microglial cells after priming and subsequent stimulation with LPS. 
Cells have been seeded in 6 replicates per experiment and stimulated as mentioned before using the “two 
hit” approach, measured by the Seahorse assay. Overall the PI3Kγ-/- (B) microglial cells show enhanced 
levels of ECAR compared to the wild-type (A) and PI3KγKD/KD (C) microglial cells under the stressed 
conditions (E), but not under baseline conditions (D). Wild-type microglia primed with 1 fg/mL display 
increased extracellular acidification rates compared to UP state under stressed (E), but not in the baseline 
(D) condition. PI3Kγ-/- and PI3KγKD/KD cells showed significantly decreased ECAR values by priming 
with 100 ng/ml LPS (D). ECAR values were normalized to the corresponding cell densities and the data 
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are shown as XY time-dependent graphs (A, B, C)  as well quantified and showed as boxplots and 
whiskers (D, E), *p <0.05, * vs. unprimed condition (2-way-ANOVA) and §p <0.05, § vs. wild-type 
strain (1-way-ANOVA), Holm-Sidak post-test. US, unstimulated; UP, unprimed; ECAR, extracellular 
acidification rate. 
 
The above data revealed that the lipid kinase-independent activity of PI3Kγ plays a certain role 
in controlling glycolysis in primary microglial cells (Fig. 19). 
Based on the OCR and ECAR values, related metabolic parameters, such as ATP production, 
non-mitochondrial respiration, proton leakage and spare capacity were calculated in order to 
characterize further the impact of PI3Kγ on the energy metabolism of microglial cells under 
different conditions. Our data show that PI3Kγ-/- cells displayed increased levels of all the 
parameters compared with wild-type microglia (Fig. 20). 
 
Figure 20: Respiratory metabolic parameters are controlled by the lipid kinase-independent 
activity of PI3Kγ. 
ATP production (A), non-mitochondrial respiration (B), proton leak (C) and spare capacity (D) are 
mediated by the scaffold function of PI3Kγ, characterized with increased amounts in PI3Kγ-/- microglial 
cells compared to wild-type cells. Furthermore wild-type cells primed with 1 fg/mL express increased 
amounts of ATP production (A) as well as proton leak (C). PI3KγKD/KD as well wild-type cells primed 
with 100 ng/mL LPS showed decreased expression of all the parameters (A, B, C), except the spare 
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capacity (D). Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition (2-way-
ANOVA) and §p <0.05, § vs. wild-type strain (1-way-ANOVA), Holm-Sidak post-test. US, unstimulated; 
UP, unprimed; OCR, oxygen consumption rates. 
 
These data showed that during trained sensitization, wild-type microglial cells exhibited an 
increased ATP production (by 1,45 times) and proton leak (by 1,53 times), whereas the cells with 
the other genotypes under consideration do not show any differences under the same condition 
compared to the unprimed state. Under tolerance response wild-type as well PI3KγKD/KD 
microglial cells showed decreased amounts of ATP production, non-mitochondrial respiration as 
well as the proton leakage (Fig. 20). These data showed also that mitochondrial activity is 
involved in the induction of different adaptive responses controlled by PI3Kγ in microglial cells. 
Taken together these data revealed the crucial importance of metabolic changes inducing both of 
adaptive responses (trained sensitization and tolerance), tightly regulated by the lipid kinase-
independent activity of PI3Kγ. 
 
4.5. PI3Kγ regulates phagocytic activity during tolerance response in microglial cells in 
vitro 
Phagocytosis represents one of the main essential functions of the microglial cells in the CNS 
under healthy (e.g. synapse pruning) and pathological conditions (e.g. debris removal) in order to 
maintain or re-establish basic neurologic functions. In order to verify if trained sensitization or 
tolerance as adaptive immune responses induced after priming and subsequent stimulation with 
LPS could influence such a complex microglial function like phagocytosis, we performed the in 
vitro phagocytosis assay. 
Microglial cells derived from mice with different genotypes (wild-type, PI3Kγ-/- and 
PI3KγKD/KD) were used and prepared as mentioned (see 3.2.10.), and the phagocytic activity was 
assessed by adding Zymosan- FITC labeled particles. As shown in Fig. 21 trained sensitization 
provoked in wild-type microglial cell a marked reduction of phagocytic activity compared to the 
unprimed condition, whereas the tolerant state displayed an increased phagocytosis. PI3Kγ-/- cells 
displayed a significantly decreased phagocytosis indicating a lipid kinase-independent activity of 
PI3Kγ, because PI3KγKD/KD cells showed mainly a similar behavior as seen in wild-type cells. 
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Figure 21: PI3Kγ controls the phagocytic activity during trained sensitization and tolerance in 
primary microglial cells. 
Primary microglial cells were stimulated as mentioned above using the “two hit” approach. Phagocytosis 
of the FITC labeled Zymosan particles (green dots) has been quantified as shown (see 3.2.10.). Iba1 (a 
marker of microglial cells) labels primary microglial cells (red color) and DAPI (blue) the nucleus of the 
cells. (A) Representative images of phagocytosis of FITC Zymosan particles in wild-type, PI3Kγ-/- and 
PI3KγKD/KD primary microglial cells in vitro. (B) Quantification of phagocytosis represented as 
phagocytic index (the uptake rate of FITC-Zymosan particles per cell). Data are shown as boxplots and 
whiskers, *p <0.05, * vs. unprimed condition and §p <0.05, § vs. wild-type strain, 2-way-ANOVA 
(Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
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4.6.PI3Kγ mediates phagocytosis and metabolic changes by lipid kinase-independent 
control of cAMP  
Taking under consideration that the scaffold function of PI3Kγ and its impact on microglial 
cAMP signaling appears to be a key mediator of metabolic changes and phagocytic activity in 
microglial cells during trained sensitization and tolerance, we intended to assess intracellular 
cAMP content in microglial cells under these conditions. As shown in Fig. 22, increased levels 
of cAMP are displayed in PI3Kγ-/- microglial cells, compared to the wild-type cells. 
Furthermore, a significant cAMP reduction occurred in wild-type cells after high dose priming 
and re-stimulation. 
 
Figure 22: The effect of PI3Kγ on the cAMP levels during adaptive responses in primary microglial 
cells. 
Microglial cells (wild-type, PI3Kγ-/- and PI3KγKD/KD) have been stimulated using the “two hit” approach 
and the cAMP levels have been measured using the cAMP GloAssayKit. Data are shown as boxplots and 
whiskers, *p <0.05, * vs. unprimed condition and §p <0.05, § vs. wild-type strain, 2-way-ANOVA 
(Holm-Sidak post-test). US, unstimulated; UP, unprimed. 
 
 
4.7. PI3Kγ mediates phagocytosis during tolerance development in vivo 
In order to verify the biological role of a sustained impact of PI3Kγ on phagocytosis owing to 
induced tolerance, an animal experiment has been performed. 
Data indicate a quite similar behavior of microglial cells in the brain as documented under cell 
culture conditions. Most strikingly, in brains of wild-type mice with induced microglial tolerance 
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behavior was found an enhanced phagocytic activity (Fig. 23). Furthermore, microglial cells in 
brains of PI3Kγ-/- mice displayed a reduced phagocytic activity as seen in previous studies, as for 
our in vitro phagocytosis, where high doses of LPS induced increased phagocytic activity of 
microglial cells in the wild-type mice. Furthermore the lipid kinase-independent function of 
PI3Kγ mediates the phagocytic activity in the microglial cells in brain issue during both of 
adaptive responses, trained sensitization and tolerance. 
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Figure 23: Scaffold function of PI3Kγ mediates phagocytic activity in microglial cells in vivo. 
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3 months old mice (WT, PI3Kγ-/- and PI3KγKD/KD) were used for the experiment. Mice were initially injected with either low-dose LPS (0.025 
mg/kg, i.p.) or high dose LPS (10 mg/kg, i.p.) for priming and 3 days later with a subsequent application of 10 mg/kg, i.p. LPS. Phagocytosis of 
the FITC labeled Zymosan particles has been quantified as mentioned (see. 3.2.11.). Markers such as Iba1 (microglial cells), and GFP (FITC 
labeled Zymosan particles) were used. (A) Representative images of phagocytosis of FITC Zymosan particles in wild-type, knock-out and kinase-
dead primary microglial cells in vivo. (B) Quantification results (percentage) of the of Iba-1 positive cells per voxel mm
3
 containing Zymosan 
particles. Data are shown as boxplots and whiskers, *p <0.05, * vs. unprimed condition and §p <0.05, § vs. wild-type strain, 2-way-ANOVA 
(Holm-Sidak post-test). 
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Our findings indicate PI3Kγ-dependent suppression of cAMP signaling as a critical regulatory 
element of microglial phagocytosis in vitro as well as in vivo. 
 
4.8. Cytokine profile in blood plasma and brain tissue are regulated by kinase activities 
of PI3Kγ 
Initially we showed under in vitro conditions that cells primed with low-dose LPS induce 
increased production of pro-inflammatory cytokines - trained sensitization, different from high-
dose primed microglia that induced a tolerance response characterized with decreased production 
of TNF-α and IL-6. Furthermore we showed that lipid kinase-dependent activity of PI3Kγ 
mediates the cytokine production in microglial cells. 
In order to investigate the role of PI3Kγ in regulating cytokine production under conditions of 
trained sensitization as well as tolerance induced under in vivo conditions, the cytokine profile 
was estimated in blood and brain tissue obtained from mice after priming with low as well as 
high doses of LPS in 3 month old mice (WT, PI3Kγ-/- and PI3KγKD/KD). As shown in Fig. 24, 
TNF-α and IL-6 produced in the blood plasma after subsequent injection displayed increased 
levels in wild-type compared to PI3Kγ-/- and PI3KγKD/KD, representing as shown above in vitro 
the importance of lipid kinase-dependent function of PI3Kγ mediating the cytokine profile in 
vivo. In addition, brain cytokines (TNF-α, IL-6) were affected also by the kinase activity of 
PI3Kγ, especially in the low-dose injected mice strains. 
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Figure 24: Lipid kinase-dependent role of PI3Kγ regulates the cytokine production in blood plasma 
and brain tissue. 
3 months old mice (WT, PI3Kγ-/- and PI3KγKD/KD) were used for the experiment. They were initially 
injected with either low dose LPS (0.025 mg/kg, i.p.) or high dose LPS (10 mg/kg, i.p.) for priming and 3 
days later with a subsequent application of 10 mg/kg, i.p. LPS. Cytokine production (normalized to total 
protein concentration) in the blood plasma (A, B) and brain (C, D) were assayed using ELISA immuno-
assay. Data are shown as boxplots and whiskers, §p <0.05, § vs. wild-type strain, 1-way-ANOVA (Holm-
Sidak post-test). 
 
Taken together, our results showed that lipid kinase-dependent function of PI3Kγ is a key 
mediator of the cytokine profile in the blood plasma and brain tissue, after subsequent 
administration of LPS.  
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V. Discussion 
 
5.1. Methodical considerations 
There is possibly some concern when recognized that rather low doses of stressors from 
microbial origin are potent to induce relevant priming effects in naïve microglial cells. 
Nevertheless, own data clearly show that priming with 1 fg/mL LPS was able to induce a 
significant increase of TNF-α and IL-6 release after repeated contact with an increased LPS dose 
5 days after the first PAMP contact (see Fig. 5 and 8). In order to verify these findings regarding 
dose dependency, we performed experiments targeting estimation of lower limit of LPS 
concentration which is potent to induce trained sensitization. As clearly shown in Fig. 25 a LPS 
concentration just below the dosage used to induce priming for trained sensitization (e.g., 0.3 
fg/mL) as well as a stepwise higher dose (e.g., 3 fg/mL) failed to induce an enduring state of 
trained sensitization in cultured microglial cells. Therefore, the dose of 1 fg/mL remained the 
optimal priming dose to induce significant production of different inflammatory mediators. 
 
Figure 25: LPS dose investigations for the induction of trained sensitization in microglial cells. 
Microglial cells have been stimulated using “two hit” approach and analyzed with ELISA immuno-assay 
(normalized to total protein concentration) for: TNF-α (A) and IL-6 (B) production. Data are shown as 
boxplots and whiskers, *p <0.05, * vs. unprimed condition (grey column), 2-way-ANOVA (Holm-Sidak 
post-test). US, unstimulated; UP, unprimed. 
 
Besides, there is probably an age-dependent modification of priming sensitivity as reported 
previously (Godbout et al. 2005). Own unpublished data show that – in contrast to microglial 
cells harvested from newborn mice, used in this study - cultured microglial cells obtained from 
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adult mouse brain did not show trained sensitization, whereas tolerance was partly more 
pronounced (Lajqi et al. in prep.). These data suggest that microglial cells, probably with missing 
previous PAMP contact (e.g. really naïve cells) exhibit an extremely high sensitivity for TLR-
dependent activation (Nikodemova et al. 2016), whereas resident microglial cells with 
presumably a certain history of PAMP (as well as DAMP) contacts develop possibly a (long-
lasting) tolerance. 
Interestingly, the dose of 1 fg/mL LPS represents about 122.868 molecules of LPS priming 
microglial cells, thus inducing trained sensitization after subsequent challenge. Several studies 
have shown that TLR4 can sense LPS concentrations in a range of picomolar down to 
femtomolar (Morin et al.; Dinarello 1992; Wilson et al. 2002; Paramo et al. 2016; Civciristov et 
al. 2018). This sensitivity of TLR4 is mainly adapted by the co-activity of anchor proteins such 
as cluster of differentiation 14 (CD14) and MD-2 (Dziarski and Gupta 2000; Gioannini et al. 
2004). Furthermore, microglial cells survey in a microenvironment - central nervous system, 
which is markedly protected from the outside environment including circulating blood, where 
occurrence of certain values of PAMPs like LPS has to be assumed. Therefore, it is not 
surprising that naïve (newborn) microglial cells display an increasing affinity to sense low 
PAMP doses and being more susceptible than blood-born immune cells (White et al. 1998). 
Our research study identifies the pathogen-dose as the critical mediator for the induction of both 
of adaptive responses, trained sensitization and tolerance in microglial cells. Furthermore this 
study gives more insights about the sensitivity of microglial cells memorizing very low levels of 
different PAMPs.    
  
68 
 
5.2. Discussion of research findings 
 
5.2.1. Dose-dependent induction of trained sensitization and tolerance in microglial 
cells 
Current investigations demonstrated that the innate immune cells (monocytes, macrophages and 
brain resident macrophages- microglia) can mount a memory-like behavior, principally similar to 
the immunological memory of the acquired arm after subsequent infection that has been termed 
as trained sensitization (Ifrim et al. 2014; Arts et al. 2016a). In order to prevent any 
misunderstanding with the actual used term of trained immunity which was conceptualized as 
long-term effect, we used the term trained sensitization which mainly represents a state of 
microglial cells displaying increased production of pro-inflammatory cytokines (TNF-α, IL-6) by 
sensing different pathogen ligands at a specific time-point (Bauer et al. 2018). In contrast, 
tolerance (desensitization) response was characterized with reduced production of pro-
inflammatory cytokines followed by increased anti-inflammatory response after repeated 
challenge by high loads of LPS (Sly et al. 2004). Only few studies have investigated long-term 
microglial functions as a result of a single immunostimulatory challenge, but none of them in the 
context of microglia displaying trained sensitization or tolerance in a dose-dependent manner 
after subsequent stimulation by different PAMPs (LPS, β-glucan). Our data showed that single 
stimulation by LPS, as well β-glucan, of the microglial cells induces a dose-dependent induction 
of pro-inflammatory cytokines (TNF-α, IL-6) (Fig. 4, 6A). Corresponding studies showed that 
monocytes sensitize priming with low-dose LPS, after repeated challenge inducing increased 
release of pro-inflammatory mediators such as cytokines (TNF-α, IL-6) and reactive oxygen 
species (ROS) (Chen et al. 2015; Yuan et al. 2016). Current data in microglial cells showed 
dose-dependent relation, where priming with low doses (especially at 1 fg/mL) LPS, after re-
challenge induced trained sensitization characterized by increased production of the pro-
inflammatory cytokine TNF-α, ROS and iNOS (Fig. 5). In contrast, priming with higher-doses 
(especially at 100 ng/mL) of LPS, after re-challenge induced prolonged reduction of the previous 
mentioned inflammatory mediators- tolerance response. Different studies postulated that priming 
of innate immune cells is shaped only by specific pathogen molecules such as β-glucan and BCG 
(Buffen et al. 2014; Ifrim et al. 2014; Saeed et al. 2014). Similarly, β-glucan primed microglial 
cells showed dose-dependent adaptive responses, where low-doses (especially 100 fg/mL) 
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triggered enhanced levels of TNF-α, whereas higher doses (especially 1 μg/mL) led to reduced 
amounts of TNF-α (Fig. 6, 7). The resulted biphasic effects by which low doses trigger 
stimulatory responses and high-dose results with suppressive responses has been termed 
hormesis (Calabrese and Baldwin 2001). Indeed, microglial cells adapt to different pathogen 
ligands (LPS, β-glucan) after re-challenge inducing biphasic hormetic responses where low doses 
led to increased production of pro-inflammatory mediators, whereas higher doses displayed 
decreased levels of the inflammatory response as shown (Fig. 5, 6, 7). Furthermore, microglial 
cells primed by different PAMPs (LPS, β-glucan) showed attenuated production levels of IL-6, 
after repeated challenge by LPS, where low-dose priming induced trained sensitization response, 
whereas high-dose priming triggered the tolerance development (Fig. 8, 9).  
Occurrence of the trained sensitization as a resistance mechanism was reported to be dependent 
on the expression of HIF-1α in monocytes (Cheng et al. 2014) followed by increased lactate 
production promoting a metabolic state toward glycolysis. Several investigations have shown 
that trained sensitization as well as tolerance are mediated by epigenetic changes followed by 
metabolic modifications (Saeed et al. 2014; Arts et al. 2016b; Liu et al. 2016). Microglial cells 
primed with low-dose LPS expressed similar phenotype as monocytes inducing increased 
expression of HIF-1α (Fig. 10B) characterized by increased lactate amounts and PFKFB3 
expression (Fig. 12) promoting the shift toward glycolysis and being responsible for the 
induction of trained sensitization. Meanwhile, a study showed that  microglial cells re-challenged 
by high loads of LPS display a tolerance response as a consequence characterized with decreased 
levels of inflammatory mediators (Schaafsma et al. 2015). Moreover, this state of tolerance is 
further characterized by increased levels of anti-inflammatory mediators, especially IL-10 and 
TGF-β (Nomura et al. 2000). Interestingly, results showed that priming with 100 ng/mL LPS 
after repeated challenge led to increased production of IL-10, as well expression of different anti-
inflammatory mediators (IL-10, TGF-β, IL-4 and Arg-1) (Fig. 11) followed by decreased 
production of pro-inflammatory mediators (TNF-α, IL-6, ROS, iNOS) as shown above and 
decreased lactate amounts (Fig. 12A). A recent complementary study done on microglial cells in 
vivo reported similar immune adaptive responses, where microglia primed with low-dose LPS 
displayed trained sensitization and higher dose repeated stimulations with LPS developed a 
tolerant state, thus affecting the formation of β-amyloid plaques (Wendeln et al. 2018). 
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Furthermore our data indicated that trained sensitization is mainly characterized by increased 
expression and production of the pro-inflammatory mediators with a shift toward glycolysis as 
metabolic state characterized by increased lactate production, and thus representing phenotype 
characteristics toward “M1”-like polarization (Kobayashi et al. 2013; Orihuela et al. 2016). 
Moreover, tolerance displayed reduced production of inflammatory markers and lactate in 
addition to increased expression levels of the anti-inflammatory mediators, exhibiting 
characteristics of “M2”-like phenotype of microglia (Landau et al. 2010; Avdic et al. 2013; 
Colonna and Butovsky 2017). Comparable findings have been reported where endotoxin 
tolerance represents a distinctive alternative activation of macrophages (M2 phenotype) (Pena et 
al. 2011).  
Taken together, these data underline the key importance of the sensing dose of stressors (here 
PAMPs) such as LPS and β-glucan for the development of innate immune-mediated adaptive 
responses after subsequent challenge by the same or different conserved structures of different 
pathogens, resulting with trained sensitization by low-dose priming and tolerance by high-dose 
priming of microglial cells. 
 
5.2.2. Lipid kinase-dependent and -independent activities of PI3Kγ mediate trained 
sensitization and tolerance in microglial cells  
Up to date, different investigations have reported a tight interplay of PI3Ks family regulating the 
induction of trained sensitivity by activating Akt/mTOR/NFκB pathway as well as tolerance by 
suppressing this pathway (Cheng et al. 2014; Poplutz et al. 2017; Xu et al. 2018). Furthermore, 
phosphoinositide 3-kinase γ (PI3Kγ) was known to mediate stress-induced immune responses 
(Jin et al. 2011). Our group reported that PI3Kγ is a key regulator of different cellular processes 
in primary microglial cells affecting the inflammatory response in addition to biological 
developments in the brain (Schmidt et al. 2013; Frister et al. 2014; Schneble et al. 2017). Latest 
reports showed a lipid kinase-dependent function of PI3Kγ regulating the cytokine production 
profile on macrophages (Luo et al. 2014; Kaneda et al. 2016). Our data showed that the induction 
of adaptive responses in microglial cells mainly characterized by different attitudes of the 
cytokine profile, in one side increased production of the pro-inflammatory cytokines (TNF-α, IL-
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6) by low-dose priming with LPS – trained sensitization, and in the other side with reduced 
inflammatory response, but enhanced levels of the anti-inflammatory cytokines such as IL-10 by 
priming with high-dose LPS – tolerance, were mediated by the lipid kinase-dependent activity of 
PI3Kγ (Fig. 13). Furthermore, extensive protein expression of PI3Kγ (Fig.14) triggered 
increasing production of TNF-α and IL-6 during trained sensitization in wild-type microglia, 
different from PI3Kγ-/- and PI3KγKD/KD cells that showed reduced cytokine production levels. 
Activation of the NFκB family, especially Rel A (p65) promotes the release of different 
inflammatory mediators (Kwon et al. 2016). Our data showed that the molecular mechanism 
behind the induction of trained sensitization in primary microglial cells relates on the p65 
activation, triggering the increased production of TNF-α and IL-6 (Fig. 15). The expression of 
p65 in wild-type cells during tolerance showed a slightly decrease compared to the unprimed 
state, leading to increased production of IL-10. Wild-type microglial cells compared to PI3Kγ-/- 
and PI3KγKD/KD expressed higher protein levels of p65 during trained sensitization and tolerance, 
confirming our previous findings about the cytokine production mediated by the lipid kinase-
dependent activity of PI3Kγ. Comparable findings were reported in macrophages showing a tight 
regulation of the p65 activity in the induction of pro- and anti-inflammatory cytokines, mediated 
by the kinase function of PI3Kγ (Kaneda et al. 2016). 
In addition Rel B, another member of the NFκB family, known to suppress the release of 
cytokines, partially by the inhibition of p65 activity (Gasparini et al. 2013), showed increased 
protein expression in PI3Kγ-/- microglial cells compared to wild-type cells, resulting with 
decreased production of TNF-α, IL-6 and IL-10 (Fig. 16). Notably, PI3KγKD/KD cells show a 
slightly tendency toward higher protein expression levels of Rel B, resulting with decreased 
amounts of cytokine production. Interestingly, p65 and Rel B relay on a kind “yin/yang” 
equilibrium where p65 induced cytokine production is partially suppressed by the activity of Rel 
B, or vice-versa, influencing the cytokine profile in different cells (Jacque et al. 2005). 
TLR4-induced activation by LPS is the key cascade triggering the NFκB translocation into the 
nucleus and thus leading to the production of pro-inflammatory mediators (Hoesel and Schmid 
2013; Liu et al. 2017). Our results showed that only wild-type microglial cells were capable to 
display both, trained sensitization and tolerance, different from PI3Kγ-/- and PI3KγKD/KD 
microglial cells that were able to mediate only tolerance response. Furthermore, our results 
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showed that both of adaptive responses in microglial cells were induced by TLR4/MyD88-
dependent pathway characterized by upregulated expression during trained sensitization and 
downregulated expression by tolerance (Fig. 17). Similarly, a report showed that downregulation 
of the surface receptor TLR4 on macrophages followed by the reduced expression of the adaptor 
gene MyD88 triggers the state of endotoxin tolerance (Nomura et al. 2000). 
 
Figure 26: Schematic model depicting the PI3Kγ signaling to promote cytokine production by the 
activation of NFκB. 
Reports have shown that PI3Kγ activation by TLR4 triggers downstream processes promoting NFκB 
activation, especially p65, thus affecting the cytokine profile in the innate immune cells (Luo et al. 2014; 
Kaneda et al. 2016). In contrast, Rel B activation suppresses the pro-inflammatory cytokine release 
(Gasparini et al. 2013).  
 
Our current findings showed for the first time that TLR4/MyD88-dependent activation of NFκB, 
especially p65, mediated by the lipid kinase-dependent function of PI3Kγ is a critical 
determinant for the induction of both, trained sensitization and tolerance response in microglial 
cells. 
Up to date, increasing studies indicated epigenetic modifications followed by metabolic changes 
as main novelties important for the induction of trained sensitization and tolerance in myeloid 
cells, especially monocytes and macrophages (Buffen et al. 2014; Saeed et al. 2014; Arts et al. 
2016a). In addition, as shown above induction of trained sensitization in wild-type microglial 
cells was characterized with increased lactate production inducing a shift toward glycolysis as 
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main metabolic process. A recent study revealed that increased oxygen consumption rates (OCR) 
and extracellular acidification rates (ECAR) represented main metabolic changes characterizing 
trained sensitization compared to their unprimed state, and thus identifying both metabolic 
processes, glycolysis and oxidative phosphorylation as main processes affecting the induction of 
adaptive processes in monocytes (Domínguez-Andrés et al. 2018). Real-time metabolic 
investigations of microglial cells from different genotypes (wild-type, PI3Kγ-/- and PI3KγKD/KD) 
showed that wild-type cells capable to induce trained sensitization by low-dose displayed higher 
baseline as well stressed OCR (Fig. 18), characterized by increasing ATP production and proton 
leak (Fig. 20 A, C) representing the oxidative phosphorylation as one of the main metabolic 
changes for the induction of adaptive responses. Furthermore, wild-type microglia primed with 
low-dose LPS expressed enhanced levels of stressed ECAR (Fig. 19), characterized by increased 
levels of lactate, shifting the metabolic process toward glycolysis. Moreover, tolerant microglia 
from PI3Kγ-/- and PI3KγKD/KD showed significantly decreased levels of baseline OCR and ECAR 
compared to their unprimed control (Fig. 18, 19), characterized also with reduced levels of 
cytokine production (TNF-α, IL-6 and IL-10) different from wild-type cells that displayed higher 
amounts (Fig. 13).  Interestingly, PI3Kγ-/- microglial cells showed increased amounts of baseline 
and stressed OCR, as well as stressed ECAR values compared to the wild-type cells, indicating a 
scaffold function of PI3Kγ mediating metabolic activities such as glycolysis and oxidative 
phosphorylation. Therefore PI3Kγ-/- cells displayed increased amounts of cAMP production 
compared to wild-type cells, confirming the lipid kinase-independent activity of PI3Kγ, mediated 
here by decreased activity of PDE (Fig. 22). Few studies have reported also the importance of the 
lipid kinase-independent activity of PI3Kγ mediating glycolysis and further hypothesized that 
could be crucial for the mediation of oxidative phosphorylation (Becattini et al. 2011; Ha et al. 
2013). Different metabolic parameters such as ATP production, non-mitochondrial respiration, 
proton leak and spare capacity were mediated by the scaffold activity of PI3Kγ, defined by 
increased levels in the PI3Kγ-/- microglial cells. Furthermore, wild-type and PI3KγKD/KD primed 
by 100 ng/mL LPS, inducing tolerance showed decreased amounts of ATP production, non-
mitochondrial respiration, proton leak and spare capacity, compared to the unprimed control 
(Fig. 20), displaying increased microglial phagocytic activity, especially in wild-type microglia 
in vitro as well in vivo (Fig. 21, 23). Our data indicated that metabolic changes indeed are 
involved in the mediation of trained sensitization as well tolerance, regulated by the lipid kinase-
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independent activity of PI3Kγ in microglial cells. Furthermore our results revealed that 
mitochondria as main organelles important for the energy support in microglial cells play a key 
role in the induction of trained sensitization and tolerance, mediated by the scaffold function of 
PI3Kγ.  
Up to date, different reports showed that activation of PI3K signaling pathway is critical for the 
regulation of epigenetic modifications, especially involved in the methylation of histones and 
thus triggering different cellular responses (Zuo et al. 2011; Toska et al. 2017; Spangle et al. 
2017). These findings showed a rationale for the putative role of PI3Kγ affecting epigenetic 
regulations, followed by metabolic changes and thus inducing trained sensitization and tolerance. 
Pathological events trigger the activation of microglial cells transforming them to active 
phagocytes, and thus serving as key cells for the maintaining and protecting the neurologic 
network in CNS from invading pathogens (Pocock and Kettenmann 2007; Kettenmann et al. 
2013). Published work from our group showed that LPS-induced phagocytic activity in 
microglial cells is mediated by downregulation of cAMP-dependent pathway, tightly mediated 
by the scaffold activity of PI3Kγ (Schmidt et al. 2013). Our investigation showed that PI3Kγ-/- 
mice strains displayed decreased phagocytic activity compared to wild-type genotype 
characterized by increased levels of cAMP production (Fig. 22), indicating lipid kinase-
independent control of cAMP by PI3Kγ as key mediator of microglial phagocytosis in vitro as 
well as in vivo (Fig. 21, 23). Furthermore, wild-type cells primed with high-dose LPS inducing 
tolerance showed increased phagocytic activity compared to unprimed control in vitro and in 
vivo. Comparable findings were reported, where microglial cells in vivo expressed increasing 
markers for the microglial phagocytosis (Wendeln et al. 2018). 
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Figure 27: Schematic overview of the lipid kinase-independent function of PI3Kγ regulating 
phagocytic activity and metabolic changes in microglial cells. 
(A) PI3Kγ mediates the activation (→) of PDE, triggering degradation of cAMP, thus leading to 
decreased levels of cAMP resulting with increased phagocytic activity (Schmidt et al. 2013). In contrast, 
(B) PI3Kγ-/- (knock-out) is unable (X) to induce the activation of PDE, leading to increased levels of 
cAMP resulting with increased metabolic activity. 
 
Taken together, our study revealed the control of cAMP levels mediated by PI3Kγ scaffold 
function, as crucial mediator for regulation of microglial phagocytosis and metabolic activities 
during trained sensitization and tolerance. 
In addition, experiments performed on the 3 month old mice strains (wild-type, PI3Kγ-/- and 
PI3KγKD/KD) revealed that mice primed with low-dose as well high-dose of LPS showed after 
subsequent injection with LPS similar regulation of the cytokine profile (TNF-α and IL-6) in 
blood plasma and brain tissue as shown in vitro in microglial cells, mediated by the lipid kinase-
dependent activity of PI3Kγ (Fig. 24). Interestingly, brain tissue cytokine production (TNF-α, 
IL-6) after subsequent injection by LPS showed increased amounts compared to previous studies 
done with single injection LPS, expressing a phenotype complementary to trained sensitization, 
whereas blood plasma cytokines (TNF-α, IL-6) showed decreased tendency compared to single 
injection studies displaying a phenotype toward tolerance response (Ndongson-Dongmo et al. 
2015; Ndongson-Dongmo et al. 2018, under revision). The importance of low- and high-dose 
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LPS in the brain was reported to affect the occurrence and severity of the neurodegenerative 
disorders in the mice, where low-dose LPS displayed increased production of pro-inflammatory 
cytokines resulting with increased accumulation of β-amyloid plaques, whereas repeated 
injection by high-dose LPS displayed reduced levels of pro-inflammatory cytokines 
characterized by reduced amounts of β-amyloid plaque accumulation  (Wendeln et al. 2018).  
Taken together, our results till now revealed the pathogen dose as key determinant for the 
induction of trained sensitization by low-dose PAMPs (LPS, β-glucan) and tolerance by high-
dose PAMPs (LPS, β-glucan) in microglial cells. Metabolic changes play a pivotal role in the 
induction of both of adaptive responses, characterized mainly also with different attitudes of 
cellular functions, especially phagocytosis, tightly mediated by the lipid kinase-dependent (e.g. 
cytokine production) and -independent (metabolic changes and phagocytosis) activities of 
PI3Kγ. Exhibition of putative effects of trained sensitization and tolerance affecting different 
neurodegenerative disorders remains so far unknown and represents a major challenge for the 
future research.   
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VI. Conclusions 
Our findings characterize the critical importance of the sensing dose of PAMPs (LPS, β-glucan) 
for induction of trained sensitization - by low priming dosages - and tolerance by high-dose 
priming of microglial cells. Furthermore, our data report that lipid kinase-dependent and -
independent (scaffold) activities of PI3Kγ mediate the cytokine profile (TNF-α, IL-6 and IL-10) 
by the activation or inhibition of the NFκB pathway, metabolic changes (glycolysis and oxidative 
phosphorylation) and cellular functions such as phagocytosis, affecting the induction of trained 
sensitization and tolerance response in microglial cells. 
Therefore, PI3Kγ was identified to be a key mediator that promotes the dose-dependent 
induction of memory-like effects imposed by transcriptional modifications and resulting 
metabolic rearrangements in microglial cells. 
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